0001144204-16-133603.txt : 20161114 0001144204-16-133603.hdr.sgml : 20161111 20161114064024 ACCESSION NUMBER: 0001144204-16-133603 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 63 CONFORMED PERIOD OF REPORT: 20160930 FILED AS OF DATE: 20161114 DATE AS OF CHANGE: 20161114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Vuzix Corp CENTRAL INDEX KEY: 0001463972 STANDARD INDUSTRIAL CLASSIFICATION: RADIO & TV BROADCASTING & COMMUNICATIONS EQUIPMENT [3663] IRS NUMBER: 043392453 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-35955 FILM NUMBER: 161990308 BUSINESS ADDRESS: STREET 1: 25 HENDRIX ROAD STREET 2: SUITE A CITY: WEST HENRIETTA STATE: NY ZIP: 14586 BUSINESS PHONE: 585-359-5900 MAIL ADDRESS: STREET 1: 25 HENDRIX ROAD STREET 2: SUITE A CITY: WEST HENRIETTA STATE: NY ZIP: 14586 10-Q 1 v452286_10q.htm FORM 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

þ	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended September 30, 2016

¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number 001-35955

VUZIX CORPORATION

(Exact name of registrant as specified in its charter)

Delaware		04-3392453
State or other jurisdiction of incorporation or organization		(I.R.S. Employer Identification No.)

25 Hendrix Road, Suite A West Henrietta, New York		14586
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (585) 359-5900

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to filing requirements for the past 90 days. Yes þ No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes þ No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer”, “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ¨

Accelerated filer ¨

Non-accelerated filer ¨

(Do not check if a smaller reporting
company)

Smaller reporting company þ

Indicate by check mark whether the registrant is a shell company (as defined in rule 12b-2 of the Exchange Act). Yes ¨ No þ

As of November 14, 2016, there were 17,560,686 shares of the registrant’s common stock outstanding.

Vuzix Corporation

INDEX

		Page No.

Part I – Financial Information		3

Item 1.	Condensed Consolidated Financial Statements (Unaudited):	3

	Consolidated Balance Sheets as of September 30, 2016 and December 31, 2015	3

	Consolidated Statement of Changes in Stockholder’s Equity for the Nine months ended September 30, 2016	4

	Consolidated Statements of Operations for the Three and Nine months ended September 30, 2016 and 2015	5

	Consolidated Statement of Cash Flows for the Nine months ended September 30, 2016 and 2015	6

	Notes to the Unaudited Condensed Consolidated Financial Statements	7

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	16

Item 3.	Quantitative and Qualitative Disclosures About Market Risk	28

Item 4.	Controls and Procedures	28

Part II – Other Information		29

Item 1.	Legal Proceedings	29

Item 1A.	Risk Factors	29

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	29

Item 3.	Defaults Upon Senior Securities	29

Item 4.	Mine Safety Disclosure	29

Item 5.	Other Information	29

Item 6.	Exhibits	30

Signatures		31

Part 1: FINANCIAL INFORMATION

Item 1:

Condensed Consolidated Financial Statements

VUZIX CORPORATION

CONSOLIDATED BALANCE SHEETS

	(Unaudited)
	September 30,			December 31,
	2016			2015
ASSETS
Current Assets
Cash and Cash Equivalents	$	5,941,661		$	11,877,058
Accounts Receivable		119,285			325,694
Inventories, Net		3,972,543			3,349,098
Manufacturing Vendor Prepayments		205,940			369,411
Prepaid Expenses and Other Assets		832,086			608,950

Total Current Assets		11,071,515			16,530,211

Fixed Assets, Net		3,070,452			2,015,433
Patents and Trademarks, Net		540,060			515,697
Software Development Costs, Net		286,450			501,288

Total Assets	$	14,968,477		$	19,562,629

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current Liabilities
Accounts Payable	$	1,529,554		$	907,434
Current Portion of Long-Term Debt, net of discount		1,333,709			55,790
Customer Deposits		43,383			27,847
Unearned Revenue		370,277			69,481
Accrued Expenses		1,053,288			734,497
Income and Other Taxes Payable		23,837			7,073

Total Current Liabilities		4,354,048			1,802,122

Long-Term Liabilities
Long-Term Derivative Liability		297,919			240,786
Long-Term Portion of Term Debt, net of discount		—			1,227,550
Long-Term Portion of Accrued Expenses		30,833			38,333
Long-Term Portion of Accrued Interest		—			160,967

Total Long-Term Liabilities		328,752			1,667,636

Total Liabilities		4,682,800			3,469,758

Stockholders’ Equity
Preferred Stock		50			50
Common Stock		17,478			16,088
Additional Paid-in Capital		80,772,108			73,665,601
Accumulated Deficit		(70,503,959	)		(57,588,868	)

Total Stockholders’ Equity		10,285,677			16,092,871

Total Liabilities and Stockholders’ Equity	$	14,968,477		$	19,562,629

The accompanying notes are an integral part of these consolidated financial statements.

VUZIX CORPORATION

CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS’ EQUITY

(Unaudited)

	Preferred Stock				Common Stock				Additional Paid-In			Accumulated
	Shares		Amount		Shares		Amount		Capital			Deficit			Total

Balance — December 31, 2015		49,626	$	50		16,087,951	$	16,088	$	73,665,601		$	(57,588,868	)	$	16,092,871

Stock Based Compensation Expense										540,843						540,843
Public Offering						1,150,000		1,150		6,611,350						6,612,500
Public Offering Issuance Costs										(847,805	)					(847,805	)
Cashless Option Exercise						632		1		(1	)					—
Conversion of Note Payable & Accrued Interest						152,016		152		341,882						342,034
Exercise of Warrants						15,000		15		44,985						45,000
Common Stock Awards						40,000		40		241,260						241,300
Stock Issues for Services						32,578		32		173,993						174,025
Net Loss for the Nine months ended September 30, 2016													(12,915,091	)		(12,915,091	)

Balance — September 30, 2016		49,626	$	50		17,478,177	$	17,478	$	80,772,108		$	(70,503,959	)	$	10,285,677

The accompanying notes are an integral part of these consolidated financial statements.

VUZIX CORPORATION

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

	For Three Months						For Nine Months
	Ended September 30,						Ended September 30,
	2016			2015			2016			2015

Sales of Products	$	582,549		$	890,629		$	1,367,766		$	2,014,015
Sales of Engineering Services		-			79,750			139,500			193,331

Total Sales		582,549			970,379			1,507,266			2,207,346

Cost of Sales — Products		819,116			612,346			2,069,964			1,590,284
Cost of Sales — Engineering Services		—			31,900			39,060			77,332

Total Cost of Sales		819,116			644,246			2,109,024			1,667,616
Gross Profit (Loss) (exclusive of depreciation shown separately below)		(236,567	)		326,133			(601,758	)		539,730
Operating Expenses:
Research and Development		2,177,957			944,426			5,121,713			2,191,624
Selling and Marketing		839,497			469,443			2,627,543			1,172,252
General and Administrative		1,274,698			1,120,982			3,350,441			5,079,131
Depreciation and Amortization		196,370			88,285			549,244			226,472

Loss from Operations		(4,725,089	)		(2,297,003	)		(12,250,699	)		(8,129,749	)

Other Income (Expense)
Interest Income		8,144			12,621			20,923			12,621
Other Taxes		(19,124	)		(30,443	)		(53,749	)		(44,508	)
Foreign Exchange (Loss) Gain		(13,781	)		287			(21,267	)		1,335
Gain (Loss) on Derivative Valuation		(59,120	)		58,239			(57,133	)		(968,467	)
(Loss) on Fixed Asset Disposal		(25,890	)		—			(25,890	)		—
Amortization of Senior Term Debt Discount		(155,313	)		(116,008	)		(391,334	)		(635,949	)
Amortization of Deferred Financing Costs		(11,707	)		(11,708	)		(34,867	)		(34,740	)
Interest Expenses		(33,981	)		(40,956	)		(101,075	)		(118,693	)

Total Other Income (Expense)		(310,772	)		(127,968	)		(664,392	)		(1,788,401	)

Loss Before Income Taxes		(5,035,861	)		(2,424,971	)		(12,915,091	)		(9,918,150	)
Provision (Benefit) for Income Taxes		—			—			—			—

Net Loss		(5,035,861	)		(2,424,971	)		(12,915,091	)		(9,918,150	)
Preferred Stock Dividends		(410,153	)		(386,377	)		(1,203,693	)		(1,121,860	)

Loss Attributable to Common Stockholders	$	(5,446,014	)	$	(2,811,348	)	$	(14,118,784	)	$	(11,040,010	)

Loss per Share
Basic and Diluted Loss per Share (Note 2)	$	(0.32	)	$	(0.18	)	$	(0.86	)	$	(0.73	)
Weighted-average Shares Outstanding Basic and Diluted		17,216,374			15,934,279			16,489,522			15,207,545

The accompanying notes are an integral part of these condensed consolidated financial statements

VUZIX CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

	For the Nine Months Ended
	September 30,
	2016			2015

Cash Flows from Operating Activities
Net Loss	$	(12,915,091	)	$	(9,918,150	)
Non-Cash Adjustments
Depreciation and Amortization		549,244			226,472
Amortization of Software Development Costs in Cost of Sales products		214,836			214,838
Loss on Disposal of Fixed Assets		25,890			—
Common Stock Awards Compensation Expense		241,300			1,669,700
Stock Based Option Compensation Expense		540,843			401,863
Amortization of Term Debt Discount and Debt Issuance Costs		426,201			670,689
Common Stock and Warrants Issued for Services		174,025			984,559
(Gain) Loss on Derivative Valuation		57,133			968,467
(Increase) Decrease in Operating Assets
Accounts Receivable		206,409			(281,034	)
Inventories		(623,445	)		(849,958	)
Manufacturing Vendor Prepayments		163,471			(1,122,184	)
Prepaid Expenses and Other Assets		(223,135	)		(33,579	)
Increase (Decrease) in Operating Liabilities
Accounts Payable		622,119			(1,785,638	)
Accrued Expense		311,291			16,410
Customer Deposits		15,536			(100,016	)
Unearned Revenue		300,796			20,628
Income and Other Taxes Payable		16,764			(25,630	)
Accrued Interest & Long-Term Accrued Interest		(142,347	)		67,858

Net Cash Flows Used in Operating Activities		(10,038,160	)		(8,874,705	)

Cash Flows from Investing Activities
Purchases of Fixed Assets		(1,551,141	)		(553,448	)
Investments in Patents and Trademarks		(103,375	)		(166,305	)

Net Cash Used in Investing Activities		(1,654,516	)		(719,753	)

Cash Flows from Financing Activities
Proceeds from Exercise of Warrants		45,000			1,262,626
Repayment of Capital Leases		—			(16,882	)
Repayment of Long-Term Debt and Notes Payable		(52,416	)		(150,362	)
Proceeds from Public Offering		6,612,500			—
Issuance Costs of Public Offering		(847,805	)		—
Proceeds from Preferred Stock Offering		—			24,813,000
Issuance Costs of Preferred Stock Offering		—			(214,169	)
Net Change in Line of Credit		—			(112,500	)

Net Cash Flows Provided by Financing Activities		5,757,279			25,581,713

Net (Decrease) Increase in Cash and Cash Equivalents		(5,935,397	)		15,987,255
Cash and Cash Equivalents — Beginning of Period		11,877,058			84,967

Cash and Cash Equivalents — End of Period	$	5,941,661		$	16,072,222
Supplemental Disclosures
Interest Paid in Cash	$	7,860		$	21,690
Common Stock and Warrants Issued for Services	$	—		$	898,537
Conversion of Debt and Accrued Interest	$	342,034		$	427,500
Reclassification of Derivative Liability to Paid-In Capital upon Waiver of Certain Anti-Dilutive Provisions of Warrants and Convertible Debt	$	—		$	11,543,354
Reclassification of Derivative Liability Upon Warrant Exercises	$	—		$	2,855,463

The accompanying notes are an integral part of these condensed consolidated financial statements.

VUZIX CORPORATION AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Note 1 — Basis of Presentation

The accompanying unaudited Condensed Consolidated Financial Statements of Vuzix Corporation and Subsidiaries (“the Company") have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X of the Securities and Exchange Commission. Accordingly, the unaudited Condensed Consolidated Financial Statements do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. The condensed consolidated balance sheet as of December 31, 2015 was derived from the audited Consolidated Financial Statements in Form 10-K.

The accompanying Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements of the Company as of December 31, 2015, as reported in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission.

The results of the Company’s operations for any interim period are not necessarily indicative of the results of the Company’s operations for any other interim period or for a full fiscal year.

For the nine months ended September 30, 2016 one customer accounted for approximately 14% of sales. There was no single customer in the 2015 period that accounted for over 10% of total sales.

The accompanying Condensed Consolidated Financial Statements have been prepared assuming that we will continue as a going concern. This basis of accounting contemplates the recovery of our assets and the satisfaction of liabilities in the normal course of business. These Condensed Consolidated Financial Statements do not include any adjustments to the specific amounts and classifications of assets and liabilities, which might be necessary should we be unable to continue as a going concern. The net loss for the nine months ending September 30, 2016 was $12,915,091. The Company has incurred a net loss consistently over the last 2 years. The Company incurred annual net losses of $13,427,478 in 2015 and $7,868,858 in 2014, and has an accumulated deficit of $70,503,959 as of September 30, 2016.

The Company’s cash requirements are primarily for funding operating losses, working capital, research, debt service and capital expenditures. Our cash requirements related to funding operating losses depend on numerous factors, including new product development activities, our ability to commercialize our products, our products’ timely market acceptance, selling prices and gross margins, and other factors. Historically, the Company has met these cash needs by borrowings under notes, sales of convertible debt, and the sales of equity.

On July 11, 2016, the Company closed its public offering of 1,150,000 shares of common stock, at a public offering price of $5.75 per share. Total gross proceeds from the public offering were $6,612,500. Net proceeds after underwriting discounts and commissions and other offering expenses payable by Vuzix were $5,764,695.

The Company will need to grow its business significantly to become profitable and self-sustaining on a cash flow basis or it will be required to raise new capital. The Company expects to begin shipping all new models and products during the fourth quarter of 2016 as compared to its offerings in 2015. However, if these products are not successful within a reasonable time period or the sales growth ramp is slower than forecast, we will have to raise additional capital to maintain operations and/or materially reduce our operating costs and slow the pace of development on further new products.

If the Company raises additional funds, the ownership interest of existing stockholders may be diluted. The amount of such dilution could increase due to the issuance of new warrants or securities with other dilutive characteristics, such as full ratchet anti-dilution clauses or price resets.

However, there can be no assurance that we will be able to raise capital in the future or that if we raise additional capital it will be sufficient to execute our business plan. To the extent that we are unable to raise sufficient additional capital, we will be required to substantially modify our business plan and our plans for operations, which could have a material adverse effect on us and our financial condition.

Note 2 – Loss Per Share

Basic loss per share is computed by dividing the loss attributable to common stockholders by the weighted average number of common shares outstanding for the period. Diluted earnings per share reflects the potential dilution from the assumed exercise of stock options and warrants, and the conversion of any convertible debt and convertible preferred shares. During periods of net loss, all common stock equivalents are excluded from the diluted EPS calculation because they are antidilutive. Since the Company reported a net loss for the three and nine months ended September 30, 2016 and 2015, the calculation for basic and diluted earnings per share is considered to be the same, as the impact of potential common shares is anti-dilutive. As of September 30, 2016 and December 31, 2015, there were 7,241,147 and 7,366,036 respectively, common stock share equivalents potentially issuable under convertible debt agreements, conversion of preferred shares, options, and warrants that could potentially dilute basic earnings per share in the future.

Note 3 — Inventories, Net

Inventories are stated at the lower of cost (determined on the first-in, first-out or specific identification method) or market and consisted of the following:

	September 30, 2016			December 31, 2015

Purchased Parts and Components	$	3,260,075		$	3,069,261
Work in Process		356,407			154,880
Finished Goods		973,348			612,451
Less: Reserve for Obsolescence		(617,287	)		(487,494	)
Net	$	3,972,543		$	3,349,098

Note 4 — Accrued Expenses

Accrued expenses consisted of the following:

	September 30, 2016		December 31, 2015

Accrued Wages and Related Costs	$	90,316	$	102,792
Accrued Compensation		358,719		358,719
Accrued Professional Services		193,196		89,000
Accrued Warranty Obligations		55,511		64,002
Accrued Interest		345,546		109,984
Other Accrued Expenses		10,000		10,000

Total	$	1,053,288	$	734,497

Included in the above accrued compensation are amounts owed to officers of the Company for services rendered that remain outstanding. The amounts were $358,719 as of September 30, 2016 and December 31, 2015. The related interest amounts on the officers’ accrued compensation included in Accrued Interest were $131,687 and $97,801 respectively as of September 30, 2016 and December 31, 2015. These amounts are not subject to a fixed repayment schedule and they bear interest at a rate of 8% per year, compounding monthly. The related interest expense amounts for the nine months ended September 30, 2016 and 2015 were $28,492 and $29,340 respectively.

The Company has warranty obligations in connection with the sale of certain of its products. The warranty period for its products is generally one year except in certain European countries where it is two years. The costs incurred to provide for these warranty obligations are estimated and recorded as an accrued liability at the time of sale. The Company estimates its future warranty costs based on product-based historical performance rates and related costs to repair. The changes in the Company’s accrued warranty obligations for the nine months ended September 30, 2016 were as follows:

Accrued Warranty Obligations at December 31, 2015	$	64,002
Reductions for Settling Warranties		(58,320	)
Warranties Issued During Period		49,829

Accrued Warranty Obligations at September 30, 2016	$	55,511

Note 5 – Derivative Liability and Fair Value Measurements

The Company recognized a derivative liability for the warrants to purchase shares of its common stock issued in connection with the equity offering and related debt conversions on August 5, 2013. Those warrants have a cashless exercise provision and an exercise price that is subject to adjustment in the event of subsequent equity sales at a lower purchase price (subject to certain exceptions) along with full-ratchet anti-dilution provisions. In accordance with FASB ASC 815-10-25, we measured the derivative liability using a Monte Carlo Options Lattice pricing model at their issuance date and subsequently remeasured the liability on each reporting date.

Accordingly, at the end of each quarterly reporting date, the derivative fair market value is remeasured and adjusted to current market value. As at September 30, 2016 and December 31, 2015 a total of 45,100 warrants were outstanding that contained a full-ratchet anti-dilution provision. In connection with the closing of the Series A Private Placement on January 2, 2015, holders of approximately 86% of outstanding warrants issued by the Company in its 2013 public offering and in connection with the conversion by certain holders of the Company’s outstanding debt in connection with the Company’s public offering (collectively, the “Public Offering Warrants”) agreed to irrevocably waive their rights to anti-dilution protection under Section 2(b) of the Public Offering Warrants in the event the Company issues additional securities at a per share price lower than the exercise price of the Public Offering Warrants (the “Public Offering Warrant Waiver”). As a result the related derivative liability was reversed to Nil on January 2, 2015 and reclassified into stockholders equity under Additional Paid-in Capital.

The Company recognized a derivative liability during the year ended December 31, 2014 for the $3,000,000 of senior convertible notes issued on June 3, 2014, with a conversion price that is subject to adjustment in the event of subsequent equity sales at a lower purchase price (subject to certain exceptions). In accordance with FASB ASC 815-10-25, we measured the derivative liability of this embedded conversion option using a Monte Carlo Options Lattice pricing model at the June 3, 2014 issuance date as $1,938,988. The value of the derivative liability at issuance was recorded as a discount against the notes in the Long-Term Liabilities section of the balance sheet. Accordingly, at the end of each quarterly reporting date the derivative fair market value is remeasured and adjusted to current market value.

In connection with the closing of the Series A Private Placement on January 2, 2015, each of the holders of notes issued by the Company on June 3, 2014 (the “June 2014 Notes”) agreed to irrevocably waive their rights to anti-dilution protection under Section 5(b) of the June 2014 Notes in the event the Company issues additional securities at a per share price lower than the conversion price of the June 2014 Notes (the “June 2014 Note Waiver”). As a result this derivative liability was reversed to Nil and reclassified into stockholders equity under Additional Paid-in Capital.

The Company has adopted FASB ASC Topic 820 for financial instruments measured at fair value on a recurring basis. FASB ASC Topic 820 defines fair value, establishes a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements.

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. FASB ASC Topic 820 establishes a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include:

- Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;

- Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

- Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

The carrying amount of cash and cash equivalents, accounts receivable, accounts payable, and accrued expenses approximates their fair value due to their short maturity. The carrying amount of notes payable approximates fair value because stated or implied interest rates approximate current interest rates that are available for debt with similar terms.

We measure certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis are as follows at September 30, 2016:

	Total		Level 1		Level 2		Level 3

Warrant Liability	$	297,919	$	—	$	—	$	297,919
Total liabilities measured at fair value (Long-Term)	$	297,919	$	—	$	—	$	297,919

We measure certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis are as follows at December 31, 2015:

	Total		Level 1		Level 2		Level 3
Warrant Liability	$	240,786	$	—	$	—	$	240,786
Total liabilities measured at fair value (Long-Term)	$	240,786	$	—	$	—	$	240,786

Fair value – December 31, 2015	$	240,786

Change in fair value for the period of warrant derivative liability		57,133

Fair value – September 30, 2016	$	297,919

The Monte Carlo Options Lattice pricing model was used to estimate the fair value of the warrants outstanding:

	September 30, 2016			December 31, 2015
Assumptions for Pricing Model:
Expected term in years		1.85			2.60
Volatility		116	%		103	%
Risk-free interest rate		0.88	%		1.06	%
Expected annual dividends		None			None

Fluctuations in the variables used in calculating the value of the Company’s derivative liability could have a significant impact on the resulting valuation.

Note 6 — Long-Term Debt

Long-term debt consisted of the following:

	September 30, 2016			December 31, 2015

Note payable for research and development equipment. The principal is subject to a fixed semi-annual repayment schedule commencing October 31, 2013 over 48 months. The note carries a 0% interest rate.	$	24,459		$	59,917
The note carries a 0% interest rate, but imputed interest has been accrued based on a 12% discount rate and is reflected as a reduction in the principal.		(2,109	)		(21,085	)
Note payable for which the principal and interest is subject to a fixed blended repayment schedule of 36 months, commencing July 15, 2013. The loan bears interest at 12% per year and is secured by a subordinated position in all the assets of the Company.		—			16,958
Convertible, Senior Secured Notes payable. The principal is due June 3, 2017 and no principal payments are required prior to maturity. The notes carry a 5% interest rate, payable upon the notes’ maturities. Both the principal plus accrued interest is convertible into shares of the Company’s common stock at $2.25 per share, subject to normal adjustments. The notes are secured by a first security position in all the assets of the Company.		1,591,739			1,915,155
Convertible, Senior Secured Notes Payable Issuance Costs of $139,340, net of accumulated amortization. The estimated aggregate amortization expense is approximately $11,000 for the remainder of fiscal 2016 and approximately $20,000 in the following fiscal year.		(31,207	)		(66,074	)
Unamortized debt discount related to derivative liability associated with above notes’ conversion price that was subject to adjustment in the event of subsequent equity sales at a lower purchase price (subject to certain exceptions). Upon issuance on June 3, 2014 the discount was $1,938,988.		(249,173	)		(621,531	)

		1,333,709			1,283,340
Less: Amount Due Within One Year		(1,333,709	)		(55,790	)

Amount Due After One Year	$	—		$	1,227,550

The calendar year aggregate maturities for all long-term debt exclusive of discounts as of September 30, 2016 are as follows:

Total Aggregate Maturity For Period	Amounts

2016	$	24,459
2017		1,591,739
Total Required Principal Payments Exclusive of Debt Discounts		1,616,198
Total Unamortized Debt Discounts and Deferred Costs		(282,489	)

Total Net Long-Term Borrowings as of September 30, 2016	$	1,333,709

Of the Convertible, Senior Secured Notes, a total of $323,415 were converted into 143,740 shares of common stock and a total of $18,620 of accrued interest on these Notes were converted into 8,276 shares of common stock during the nine months ended September 30, 2016. As a result of conversion, $47,811 of unamortized discounts were written off and included in Amortization of Senior Term Debt Discount for the nine months ended September 30, 2016.

Note 7 — Income Taxes

The Company’s effective income tax rate is a combination of federal, state and foreign tax rates and differs from the U.S. statutory rate due to taxes on foreign income, permanent differences including tax-exempt interest, and the resolution of tax uncertainties, offset by a valuation allowance against U.S. deferred income tax assets.

Note 8 — Capital Stock

Preferred stock

The Company may issue shares of undesignated preferred stock in one or more series. The Board of Directors is authorized to establish and designate the different series and to fix and determine their voting powers and other special rights and qualifications. A total of 5,000,000 shares of preferred stock are authorized as of September 30, 2016 and December 31, 2015, 49,626 of which are designated as Series A Preferred Stock. There were 49,626 shares of Series A Preferred Stock issued and outstanding on September 30, 2016 and December 31, 2015.

On January 2, 2015 the Company closed a sale of Series A Preferred Stock to Intel Corporation (the “Series A Purchaser”), pursuant to which we issued and sold an aggregate of 49,626 shares of the Company’s Series A Preferred Stock, at a purchase price of $500 per share, for an aggregate purchase price of $24,813,000. Each share of Series A Preferred Stock is convertible, at the option of the Series A holder, into 100 shares of the Company’s common stock (determined by dividing the Series A Original Issue Price of $500 by the Series A Conversion Price. The Series A Conversion Price is $5.00, subject to adjustment in the event of stock splits, dividends or other combinations).

Each share of Series A Preferred Stock is entitled to receive dividends at a rate of 6% per year, compounded quarterly and payable in cash or in kind, at the Company’s sole discretion. As of September 30, 2016, total accumulated and unpaid preferred dividends were $2,717,773. As of December 31, 2015, total accumulated and unpaid preferred dividends were $1,514,081. There were no declared preferred dividends owed as of September 30, 2016 or December 31, 2015.

The Series A Purchaser has the right, but not the obligation, to participate in any proposed issuance by the Company of its securities, subject to certain exceptions and in such amount as is sufficient to maintain the Series A Purchaser’s ownership percentage in the Company, calculated immediately prior to such applicable financing, at a purchase price equal to the per share price of the Company’s securities in such applicable financing.

In connection with the Series A Private Placement, the Company entered into an investor’s rights agreement with the Series A Purchaser, pursuant to which the Company agreed to file a “resale” registration statement with the Securities and Exchange Commission (the “SEC”) covering the resale of all shares of common stock issuable upon conversion of the Series A Preferred Stock. The Company’s registration statement covering the resale of these shares was declared effective by the SEC on February 17, 2015.

Common Stock

The Company’s authorized common stock consists of 100,000,000 shares, par value of $0.001 as of September 30, 2016 and December 31, 2015. There were 17,478,177 and 16,087,951 shares of common stock issued and outstanding as of September 30, 2016 and December 31, 2015, respectively. On July 11, 2016, the Company closed its public offering of 1,150,000 shares of common stock, at a public offering price of $5.75 per share. Total gross proceeds from the public offering were $6,612,500. Net proceeds after underwriting discounts and commissions and other offering expenses payable by Vuzix were $5,764,695.

Note 9 — Stock Warrants

A summary of the various changes in warrants during the nine-month period ended September 30, 2016 is as follows:

	Number of Shares			Weighted Average Exercise Price

Outstanding at December 31, 2015		535,091		$	2.43
Issued During the Period		—			—
Exercised During the Period		(15,000	)		3.00
Expired During the Period		—			—

Outstanding at September 30, 2016		520,091		$	2.37

The outstanding warrants as of September 30, 2016 expire from November 3, 2017 to August 5, 2018. The weighted average remaining term of the warrants is 1.5 years.

A total of $45,000 in cash was received from warrant exercises for the nine months ended September 30, 2016. During the nine months ending September 30, 2015 a total of 553,250 warrants were exercised on a cash basis resulting in proceeds of $1,262,626.

Note 10 — Stock Option Plans

A summary of stock option activity for the nine months ended September 30, 2016 is as follows:

	Number of Shares			Weighted Average Exercise Price

Outstanding at December 31, 2015		1,022,789		$	4.59
Granted		60,750			6.27
Exercised		(1,000	)		2.60
Expired or Forfeited		(31,523	)		5.58

Outstanding at September 30, 2016		1,051,016		$	4.65

The weighted average remaining contractual term for all options as of September 30, 2016 and December 31, 2015 was 7.0 years and 7.6 years respectively.

As of September 30, 2016, there were 569,692 options that were fully vested and exercisable at a weighted average exercise price of $4.93 per share. The weighted average remaining contractual term on the vested options is 7.1 years.

As of September 30, 2016 there were 482,324 unvested options exercisable at a weighted average exercise price of $4.34 per share. The weighted average remaining contractual term on the unvested options is 7.0 years.

No options were exercised for cash during the nine months ended September 30, 2016 and 2015. There were 1,000 options exercised on a cashless basis during the three months ended September 30, 2016.

The weighted average fair value of option grants was calculated using the Black-Scholes-Merton option pricing method. At September 30, 2016, the Company had approximately $2 million of unrecognized stock compensation expense, which will be recognized over a weighted average period of approximately 1.6 years.

The aggregate intrinsic value that would have been received by the option holders had all holders exercised their options on September 30, 2016 was $4,791,846. The value represents the total pre-tax intrinsic value (the difference between the Company’s closing stock price on the last trading day of the third quarter of fiscal year 2016 and the exercise price, multiplied by the number of in-the-money stock options). The amount of this aggregate intrinsic value will change based on the fair market value of the Company’s stock.

The following summary table shows the assumptions used to the fair value of options granted during the nine-month period ended September 30, 2016 and their estimated value:

• Expected term in years	7.9 years
• Volatility	107.2 - 109.7		%
• Risk-free interest rate		1.28 - 1.68	%
• Expected annual dividends		None
• Fair value of options issued	$	333,434

Note 11 — Litigation

We are not currently involved in any current or pending legal proceeding or litigation.

Note 12 — Contractual Obligations

The Company has signed several lease agreements, with the largest being for its new office and manufacturing space under an operating lease that commenced October 3, 2015, that expires on October 3, 2020. The Company also leases small office spaces in England under a two-year lease and under a one year lease arrangement in Japan.

Future minimum payments required under operating lease obligations as of September 30, 2016 are as follows:

	Total Minimum Lease Payments
2016 (3 months remaining)	$	92,849
2017		346,039
2018		335,248
2019		335,248
2020		279,373
Total	$	1,388,757

Under the lease agreements described above, the Company is required to pay the pro rata share of the real property taxes and assessments, expenses and other charges associated with these facilities.

Rent expense for the nine months ended September 30, 2016 and 2015 totaled $371,239 and $65,065, respectively.

Note 13 — Recent Accounting Pronouncements

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers, an updated standard on revenue recognition. The ASU will supersede most of the existing revenue recognition requirements in GAAP and will require entities to recognize revenue at an amount that reflects the consideration to which a company expects to be entitled in exchange for transferring goods or services to a customer. This ASU also amends the required disclosures of the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. The guidance is effective for annual periods beginning after December 15, 2017, including interim periods within that period. Early adoption is permitted for annual periods beginning after December 15, 2016. The Company is determining its implementation approach and evaluating the potential impacts of the new standard on its existing revenue recognition policies and procedures.

In August 2014, the FASB issued ASU 2014-15, “Presentation of Financial Statements – Going Concern”, which provides guidance on determining when and how to disclose going-concern uncertainties in the financial statements. The new standard requires management to perform interim and annual assessments of an entity’s ability to continue as a going concern within one year of the date the financial statements are issued. An entity will be required to provide certain disclosures if conditions or events raise substantial doubt about the entity’s ability to continue as a going concern. The ASU applies to all entities and is effective for annual periods ending after December 15, 2016, and interim periods thereafter, with early adoption permitted. We are currently evaluating the impact of the adoption of ASU 2014-15 on our consolidated financial statements and have not yet determined when we will adopt the standard.

In July 2015, the FASB issued ASU 2015-11, “Inventory – Simplifying the Measurement of Inventory” which requires inventory within the scope of the standard to be measured at the lower of cost and net realizable value. Previous guidance required inventory to be measured at the lower of cost or market (where market was defined as replacement cost, with a ceiling of net realizable value and floor of net realizable value less a normal profit margin). The updated guidance is effective for interim and annual reporting periods beginning after December 15, 2016, with early adoption permitted. The Company is currently evaluating the impact, if any, the adoption of this standard will have on the consolidated financial statements.

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842). Current U.S. generally accepted accounting principles (GAAP) requires lessees and lessors to classify leases as either capital leases or operating leases. Lessees recognize assets and liabilities for capital leases but do not recognize assets and liabilities for operating leases. ASU 2016-02 requires lessees to recognize assets and liabilities for all leases (with an exception for short-term leases). The new FASB guidance will be effective for fiscal years beginning after December 15, 2018, and interim periods thereafter. The Company is currently evaluating the impact, if any, the adoption of this standard will have on the consolidated financial statements.

In March 2016, the FASB issued ASU No. 2016-09, “Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting,” which amends the current stock compensation guidance. The amendments simplify the accounting for the taxes related to stock based compensation, including adjustments to how excess tax benefits and a company's payments for tax withholdings should be classified. The standard is effective for fiscal periods beginning after December 15, 2016, with early adoption permitted. The Company is evaluating the impact, if any, the adoption of this standard will have on the consolidated financial statements and related disclosures.

In April 2016, the FASB issued ASU No. 2016-10, “Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing” to clarify two aspects of Topic 606: (i) identifying performance obligations and (ii) the licensing implementation guidance, while retaining the related principles for those areas. The Company is evaluating the impact, if any, the adoption of this standard will have on the consolidated financial statements and related disclosures.

In May 2016, the FASB issued ASU No. 2016-12, “Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients” in an effort to reduce (i) the potential for diversity at initial application and (ii) the cost and complexity of applying Topic 606 both at transition and on an ongoing basis. The Company is evaluating the impact, if any, the adoption of this standard will have on the consolidated financial statements and related disclosures.

In August 2016, the FASB issued ASU 2016-15, “Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments (a Consensus of the Emerging Issues Task Force)” in an effort to reduce existing diversity in practice related to the classification of certain cash receipts and cash payments on the statements of cash flows. The guidance addresses the classification of cash flows related to, among other things, distributions received from equity method investees. The amendments in this update are effective for annual periods beginning after December 15, 2017, and interim periods within those annual periods. The Company has not yet completed its assessment of the impact that the adoption of ASU 2016-15 will have on its consolidated financial statements.

There are no other recent accounting pronouncements that are expected to have a material impact on the condensed consolidated financial statements.

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

You should read the following discussion and analysis of financial condition and results of operations in conjunction with the financial statements and related notes appearing elsewhere in this quarterly report and in our annual report on Form 10-K for the year ended December 31, 2015.

As used in this report, unless otherwise indicated, the terms “Company,” “Vuzix” “management,” “we,” “our,” and “us” refer to Vuzix Corporation and its subsidiary.

Critical Accounting Policies and Significant Developments and Estimates

The discussion and analysis of our financial condition and results of operations are based on our unaudited condensed consolidated financial statements and related notes appearing elsewhere in this quarterly report. The preparation of these statements in conformity with generally accepted accounting principles requires the appropriate application of certain accounting policies, many of which require us to make estimates and assumptions about future events and their impact on amounts reported in our financial statements, including the statement of operations, balance sheet, cash flow and related notes. We continually evaluate our estimates used in the preparation of our financial statements, including those related to revenue recognition, bad debts, inventories, warranty reserves, product warranty, carrying value of long-lived assets, fair value measurement of financial instruments and embedded derivatives, valuation of stock compensation awards, and income taxes. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about carrying values of assets and liabilities that are not apparent from other sources. Since future events and their impact cannot be determined with certainty, the actual results will inevitably differ from our estimates. Such differences could be material to the financial statements.

We believe that our application of accounting policies, and the estimates inherently required therein, are reasonable. We periodically reevaluate these accounting policies and estimates, and make adjustments when facts and circumstances dictate a change. Historically, we have found our application of accounting policies to be appropriate, and actual results have not differed materially from those determined using necessary estimates.

Management believes certain factors and trends are important in understanding our financial performance. The critical accounting policies, judgments and estimates that we believe have the most significant effect on our financial statements are:

	•	valuation of inventories;
	•	carrying value of long-lived assets;
	•	software development costs
	•	revenue recognition;
	•	product warranty;
	•	fair value measurement of financial instruments and embedded derivatives;
	•	stock-based compensation; and
	•	income taxes.

Our accounting policies are more fully described in the notes to our condensed consolidated financial statements included in this quarterly report and in our annual report on Form 10-K for the year ended December 31, 2015. There have been no significant changes in our accounting policies for the nine-month period ended September 30, 2016.

Off Balance Sheet Arrangements

We do not have any off-balance sheet arrangements that have, or are reasonably likely to have, an effect on our financial condition, financial statements, revenues or expenses.

Business Matters

We are engaged in the design, manufacture, marketing and sale of wearable display and computing devices that are worn like eyeglasses and feature built-in video screens that enable the user to view video and digital content, such as movies, computer data, the Internet or video games. Our wearable display products, known commercially as Video Eyewear, Smart-Glasses, Augmented Reality (AR) and Virtual Reality (VR) products contain micro video displays that offer users a portable high-quality viewing experience. Our wearable display products provide virtual large high-resolution screens, that can fit in a user’s pocket or purse and can be viewed practically anywhere, anytime. They can also be used for VR and AR applications, in which the wearer is either immersed in a computer generated world or has his real world view augmented with computer generated information or graphics. Our Smart Glasses are a new category of wearable displays that have much of the capabilities of a smartphone including wireless internet access but are worn like glasses which allow for hands-free operation ideal for enterprise users. We produce both monocular and binocular devices. Vuzix wearable displays are designed to work as standalone devices or with mobile electronic devices, such as cell phones, laptop computers, tablets, portable media players and gaming systems.

All of our wearable display products feature high performance miniature display modules, low power electronics and related optical systems. Our Smart Glasses products also feature powerful mobile computers, camera, voice recognition, and WiFi/Bluetooth radios for wireless communications. We produce both monocular and binocular wearable display devices that we believe are leading solutions for many mobile computer or video viewing requirements. We focus on the consumer markets for gaming, VR and mobile video uses, while our Smart Glasses and AR products are directed primarily to the enterprise, commercial, and medical markets. The consumer electronics and mobile phone accessory markets in which we compete have been subject to rapid technological change including the rapid adoption of tablets, larger screen sizes and display resolutions on mobile phones, along with declining prices on these products, and as a result we must continue to improve our products’ performance and lower our costs. We believe our intellectual property portfolio gives us a competitive position in microdisplay electronics, waveguides, ergonomics, packaging, motion tracking and optical systems.

Recent Accounting Pronouncements

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09 ("ASU 2014-09"), Revenue from Contracts with Customers, an updated standard on revenue recognition. The ASU will supersede most of the existing revenue recognition requirements in GAAP and will require entities to recognize revenue at an amount that reflects the consideration to which a company expects to be entitled in exchange for transferring goods or services to a customer. This ASU also amends the required disclosures of the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. The guidance is effective for annual periods beginning after December 15, 2017, including interim periods within that period. Early adoption is permitted for annual periods beginning after December 15, 2016. The Company is determining its implementation approach and evaluating the potential impacts of the new standard on its existing revenue recognition policies and procedures.

There are no other recent accounting pronouncements that are expected to have a material impact on the condensed consolidated financial statements.

Results of Operations

Comparison of Three Months Ended September 30, 2016 and September 30, 2015

The following table compares the Company’s consolidated statements of operations data for the three months ended September 30, 2016 and 2015.

	3 Months Ended September 30,
	2016			2015			Dollar Change			% Increase (Decrease)

Sales of Products	$	582,549		$	890,629		$	(308,080	)		(35	)%
Sales of Engineering Services		—			79,750			(79,750	)		(100	)%

Total Sales		582,549			970,379			(387,830	)		(40	)%

Cost of Sales — Products		819,116			612,346			206,770			34	%
Cost of Sales — Engineering Services		—			31,900			(31,900	)		(100	)%

Total Cost of Sales		819,116			644,246			174,870			27	%

Gross Profit (Loss)		(236,567	)		326,133			(562,700	)		(173	)%
Gross Profit (Loss) %		(41	)%		34	%

Operating Expenses:
Research and Development		2,177,957			944,426			1,233,531			131	%
Selling and Marketing		839,947			469,443			370,054			79	%
General and Administrative		1,274,698			1,120,982			153,716			14	%
Depreciation and Amortization		196,370			88,285			108,085			122	%

Loss from Operations		(4,725,089	)		(2,297,003	)		(2,428,086	)		106	%

Other Income (Expense)
Interest Income		8,144			12,621			(4,477	)		(35	)%
Other Taxes		(19,124	)		(30,443	)		11,319			(37	)%
Foreign Exchange (Loss) Gain		(13,781	)		287			(14,068	)		(4,902	)%
Loss on Fixed Asset Disposal		(25,890	)		—			(25,890	)		(100	)%
(Loss) Gain on Derivative Valuation		(59,120	)		58,239			(117,359	)		(202	)%
Amortization of Senior Term Debt Discount & Financing Costs		(167,020	)		(127,716	)		(39,304	)		34	%
Interest Expense, net of Interest Income		(33,981	)		(40,956	)		6,975			(17	)%

Total Other Income (Expense)		(310,772	)		(127,968	)		(182,804	)		143	%

Loss Before Income Taxes		(5,035,861	)		(2,424,971	)		(2,610,890	)		108	%
Provision (Benefit) for Income Taxes		—			—			—			—

Net Loss	$	(5,035,861	)	$	(2,424,971	)	$	(2,610,890	)		108	%

Sales. There was an overall decrease in product sales for the three months ended September 30, 2016 over the same period in 2015 of $308,080 or 35%. The reduction was primarily the result of a 40% decrease in sales of the M100 Smart Glasses over the 2015 period. After the announcement of the new M300 at CES in January 2016, many customers have delayed further purchases of our smart glasses until we commence shipping the M300. Pre-order deposits for the new M300 and new orders of our M100/M300 migration packages have primarily resulted in deferred revenues and will not be recognized as revenues until those units ship to the customer. Our iWear Video Headphone sales were 29% of product revenues for the three months ending September 30, 2016 versus $0 in the same period in 2015 when it was not yet available. Revenues from this product line have continued to be constrained due to production difficulties, particularly with the tight component tolerances required to manufacture a high quality product. For the 2015 comparative period, approximately 5% of total product revenues came from the Wrap series of AR products which was discontinued in the summer of 2015, and as a result no such product revenues were reported in the 2016 period. In summary, monocular smart glasses and waveguide product sales were 69% of total product revenues versus 86% in the prior year’s period.

Sales from our engineering programs for the three months ended September 30, 2016, were $0 as compared to $79,750 over the same period in 2015.

Cost of Sales and Gross Profit (Loss). Cost of product revenues and engineering services is comprised of materials, components, labor, warranty costs, freight costs, manufacturing overhead, and the non-cash amortization of software development costs related to the production of our products and rendering engineering services. The decreased net gross profit (loss) percentage earned in the three months ended September 30, 2016 as compared to the same period in 2015 was primarily the result of lower sales levels to absorb many of our relatively fixed manufacturing overheads and amortization costs along with the fact that we earn significantly lower gross margins on iWear as compared to our smart glasses and prior Wrap AR products. Manufacturing overhead costs increased primarily due to use of temporary contract labor for iWear rework costing $39,723 and increased rent and utility cost allocations of $42,220 due to our larger plant. Freight costs continued to be substantially higher for the 2016 period as compared to 2015. As our new iWear product is bulkier and heavier and ships in a larger retail package than our prior products, the costs of air shipments have become prohibitively material now that production volumes from China have risen. We are switching to sea transport in the fourth quarter of 2016 as we expect the volumes of shipments to increase. The following table reflects the components of our cost of goods sold for products:

Component of Cost of Sales	3 Months Ended September 30, 2016			As % Related Sales			3 Months Ended September 30, 2015		As % of Related Sales			Dollar Change

Product Cost of Sales	$	297,240			51	%	$	287,302		32	%	$	9,938
Freight Costs		141,011			24	%		58,914		7	%		82,097
Manufacturing Overhead		226,034			39	%		127,988		14	%		98,046
Warranty Costs		26,662			5	%		30,020		3	%		(3,358	)
Amortization of Software Costs		71,613			12	%		71,612		8	%		1
Software Royalties		56,556			10	%		36,510		4	%		20,046

Total Cost of Sales – Products	$	819,116			141	%	$	612,346		69	%	$	206,770

Gross Profit (Loss)– Product Sales	$	(236,567	)		(41	)%	$	278,283		31	%	$	(514,850	)

Research and Development. Our research and development expenses consist primarily of compensation costs for personnel, related stock compensation expenses, third party services, purchase of research supplies and materials, and consulting fees related to research and development costs. Software development expenses to determine technical feasibility before final development and ongoing maintenance that are not capitalized are included in research and development costs.

Research and development costs were $2,177,957 for the 3 months ending September 30, 2016 as compared to $944,426 and for the three months ended September 30, 2015, an increase of $1,233,531 or 131%. Comparing the research and development costs for the three months ending September 30, 2016 versus the same period in 2015, there was an increase in 2016 salary, benefits and stock compensation expenses and recruitment costs of $271,827, primarily the result of additional R&D staff versus the same period in 2015, offset partially by a $42,581 reduction in hiring and recruitment fees; an increase in project development and research costs of $884,102 primarily related to the new M300 and the beginning of production design for manufacturing refinement activities on the M3000 Smart Glasses with our contract manufacturer who will ultimately produce the unit; an increase in $57,917 in rent and utility costs related to the expanded R&D portion of our new corporate facilities; an increase of $62,792 in external research related consulting fees; and a $24,959 decrease in travel costs related to fewer international visits to our China and our North American M300 contract manufacturer by our development teams.

Selling and Marketing. Selling and marketing costs consist of trade show costs, advertising, travel costs, sales staff compensation costs including stock compensation expense, consulting fees, PR agency fees, website costs and sales commissions paid to full-time staff and outside consultants. These costs increased overall for the three months ended September 30, 2016 by $370,054 or 79% as compared to the same period in 2015 primarily due to the following factors: higher salary, commissions, benefits and stock compensation expenses related to new staff additions totaling $137,576 domestically and in Europe; increased trade show costs of $71,329 during the quarter versus the same period in 2015 due to more frequent attendance at shows, including our first booth this September 2016 at IFA Germany; increased public relations costs of $50,687 due to the hiring of a second PR firm; a $34,131 increase in advertising and promotional expenses; a $25,126 increase in travel costs and a $15,675 increase in software subscriptions, primarily for CRM; partially offset by a $19,370 decrease in website costs.

General and Administrative. General and administrative costs include professional fees, investor relations (IR) costs including shares and warrants issued for IR services, salaries and related stock compensation, travel costs, office and rental costs. These costs increased by $153,716 or 14% for the three months ended September 30, 2016 as compared to the same period in 2015 primarily because of: increased IR activities and shareholder communications costs of $145,719; $144,631 increase in professional fees, with the majority being for SOX consultants retained to assist management in designing and implementing improvements in our financial reporting controls and accruals for expected additional audit fees, as compared to the same period in 2015 when no such consultants were retained; increased legal fees of $18,265; partially offset by a $170,679 decrease in salaries, benefits and stock compensations expenses, primarily the result of reductions in stock award expense; and a decrease in travel expenses of $22,940.

Depreciation and Amortization. Depreciation and amortization expense for the quarter ended September 30, 2016 was $196,370 as compared to $88,285 in the same period in 2015, an increase of $108,085. The increase in depreciation and amortization expense is due to new investments in depreciable assets at our new facility and new product tooling that took place after the quarter had ended September 30, 2015 during the second half of 2015.

Other Income (Expense). Total other expense was $310,772 for the three months ended September 30, 2016 compared to an expense of $127,968 in the same period in 2015. The increase in expenses was primarily the result of a loss of $59,120 on the derivative liability valuation mark-to-market revaluation for the 2016 period versus the prior 2015 quarter gain of $58,239 and a increase of $39,305 in senior debt discount and issuance expense amortization for the 2016 period versus 2015.

Provision (Benefit) for Income Taxes. There were no provisions for income taxes for the three months ended September 30, 2016 or 2015.

Comparison of Nine months ended September 30, 2016 and September 30, 2015

The following table compares the Company’s consolidated statements of operations data for the nine months ended September 30, 2016 and 2015.

	9 Months Ended September 30,
	2016			2015			Dollar Change			% Increase (Decrease)

Sales of Products	$	1,367,766		$	2,014,015		$	(646,249	)		(32	)%
Sales of Engineering Services		139,500			193,331			(53,831	)		(28	)%

Total Sales		1,507,266			2,207,346			(700,080	)		(32	)%

Cost of Sales — Products		2,069,964			1,590,284			479,680			30	%
Cost of Sales — Engineering Services		39,060			77,332			(38,272	)		(49	)%

Total Cost of Sales		2,109,024			1,667,616			441,408			26	%

Gross Profit (Loss)		(601,758	)		539,730			(1,141,488	)		(211	)%
Gross Profit (Loss) %		(40	)%		24	%

Operating Expenses:
Research and Development		5,121,713			2,191,624			2,930,089			134	%
Selling and Marketing		2,627,543			1,172,252			1,455,291			124	%
General and Administrative		3,350,441			5,079,131			(1,728,690	)		(34	)%
Depreciation and Amortization		549,244			226,472			322,772			143	%

Loss from Operations		(12,250,699	)		(8,129,749	)		(4,120,950	)		(51	)%

Other Income (Expense)
Interest Income		20,923			12,621			8,302			66	%
Other Taxes		(53,749	)		(44,508	)		(9,241	)		21	%
Foreign Exchange (Loss) Gain		(21,267	)		1,335			(22,602	)		(1,693	)%
Loss on Fixed Asset Disposal		(25,890	)		—			(25,890	)		100	%
(Loss) Gain on Derivative Valuation		(57,133	)		(968,467	)		911,334			(94	)%
Amortization of Senior Term Debt Discount & Financing Costs		(426,201	)		(670,689	)		244,488			(36	)%
Interest Expense, net of Interest Income		(101,075	)		(118,693	)		17,618			(15	)%

Total Other Income (Expense)		(664,392	)		(1,788,401	)		1,124,009			(63	)%

Loss Before Income Taxes		(12,915,091	)		(9,918,150	)		(2,996,941	)		(30	)%
Provision (Benefit) for Income Taxes		—			—			—			—

Net Loss	$	(12,915,091	)	$	(9,918,150	)	$	(2,996,941	)		(30	)%

Sales. There was an overall decrease in product sales for the nine months ended September 30, 2016 over the same period in 2015 of $646,249 or 35%. The decrease was primarily the result of a 36% decrease in sales of the M100 Smart Glasses. After the announcement of the new M300 at CES in January 2016, many customers have delayed further purchases of our smart glasses until we commence shipping the M300 Smart Glasses. Pre-orders for the new M300, including migration packages, are included primarily as deferred revenues and will not be recognized as revenues until those orders are finally shipped to the customer. Our iWear Video Headphones sales were 17% of product revenues for the nine months ending September 30, 2016 versus nil in the same period in 2015 when it was not yet available. Revenues from this product line continue to be constrained due to production difficulties, but production capacities are consistently improving. For the 2015 comparative period, approximately 7% of revenues came from the Wrap AR series of products which was discontinued in the summer of 2015, whereas no such product revenues were reported in the 2016 period. Sales of waveguide related component sales were 2% of total product revenues versus 11% in the prior period, partially due to customers awaiting shipments of the next generation of waveguides.

Sales from our engineering services programs for the nine months ended September 30, 2016, were $139,500 or 9% of total revenues as compared to $193,331 or 9% of total sales in the same period in 2015.

Cost of Sales and Gross Profit (Loss). Cost of product revenues and engineering services is comprised of materials, components, labor, warranty costs, freight costs, manufacturing overhead, and the non-cash amortization of software development costs related to the production of our products and rendering engineering services. The decreased net gross profit (loss) percentage earned in the nine months ended September 30, 2016 as compared to the same period in 2015 was primarily the result of lower sales levels to absorb many of our relatively fixed manufacturing overheads and amortization costs; as well as increased manufacturing overhead costs of $159,482 due to additional staff and larger plant facilities costs, component material scrapping costs of $89,523 related to iWear Video Headphones in the first quarter of 2016; significantly lower gross margins in iWear compared to our smart glasses and previous Wrap AR products; as well as a $209,758 increase in freight costs for the 2016 period as compared to 2015. The following table reflects the components of our cost of goods sold for products:

Component of Cost of Sales	9 Months Ended September 30, 2016			As % Related Sales			9 Months Ended September 30, 2015		As % of Related Sales			Dollar Change

Product Cost of Sales	$	795,616			58	%	$	671,375		33	%	$	124,241
Freight Costs		355,965			26	%		146,207		7	%		209,758
Manufacturing Overhead & Labor		542,072			40	%		382,590		19	%		159,482
Warranty Costs		49,829			4	%		75,091		4	%		(25,262	)
Amortization of Software Costs		214,838			16	%		214,838		11	%		—
Software Royalties		111,644			8	%		100,183		5	%		11,461

Total Cost of Sales – Products	$	2,069,964			151	%	$	1,590,284		79	%	$	479,680

Gross Profit (Loss)– Product Sales	$	(702,198	)		(51	)%	$	423,731		21	%	$	(1,125,929	)

Research and development costs were $5,121,713 as compared to $2,191,624 for the 9 months ending September 30, 2016 and 2015 respectfully, an increase of $2,930,089 or 134%. Comparing the research and development costs for the nine months ending September 30, 2016 versus the same period in 2015, there was an increase in 2016 salary, benefits and stock compensation expenses of $991,870, primarily the result of additional R&D staff versus the same period in 2015; a $62,253 reduction in new staff recruitment fees; an increase in project development and research costs of $1,628,370 primarily related to the new product development for the M300 Smart Glasses and to a smaller extent the M3000, with the majority of these amounts being spent with outside contractors which assisted in the development work; an increase in $177,639 in rent and utility costs related to the expanded R&D portion of our new corporate facilities; an increase of $120,501 in external research related consulting fees for optics and waveguide research; and a $32,877 increase in travel costs related to our China based iWear production contractor and development work at our new contractors facility of our forthcoming M300 Smart Glasses.

Selling and Marketing. Selling and marketing costs consist of trade show costs, advertising, travel costs, sales staff compensation costs including stock compensation expense, consulting fees, PR agency fees, website costs and sales commissions paid to full-time staff and outside consultants. These costs increased overall for the nine months ended September 30, 2016 by $1,455,291 as compared to the same period in 2015 primarily due to the following factors: higher salary, commissions, benefits and stock compensation expenses related to new staff additions totaling $416,330 in both North American and Europe; increased trade show costs of $390,958 due to larger exhibit booth sizes and show rentals and attendance several additional major trade shows during the year versus the same period in 2015; increased public relations costs of $238,074 due to the hiring of an additional PR and marketing service firm as compared to the 2015 period; new 2016 period video production costs of $63,143; a $161,171 increase in website costs including additions to our main new corporate and European websites; a $91,980 increase in travel costs; and a $32,121 increase in rent and utility costs and allocations with our new corporate offices.

General and Administrative. General and administrative costs include professional fees, investor relations (IR) costs including shares and warrants issued for IR services, salaries and related stock compensation, travel costs, office and rental costs. These costs decreased by $1,728,690 or 34% for the nine months ended September 30, 2016 as compared to the same period in 2015 primarily because of: lower compensation expense related to stock awards totaling $1,375,000 to our officers and directors awarded in January 2015; a $44,021 decrease in travel costs; decreased IR activities and IR consultant fees of $407,822 resulting from reductions in compensation awards of shares and warrants for these services as compared to the 2015 period; $99,598 decrease in legal fees, primarily related to a stock award made to our attorneys in January 2015; partially offset by: an increase of $20,367 in fees paid to our external board members as compared to the 2015 period when lower fee arrangements were in place; a $192,593 increase in accounting and audit fees, with the majority of the change being for SOX consultants retained to assist management in designing and implementing improvements in our financial reporting controls and accruals for expected additional external audit fees, as compared to the same period in 2015 when no such consultants were retained; and increased rent and occupancy costs of $36,937 due to our larger corporate offices.

Depreciation and Amortization. Depreciation and amortization expense for the nine months ended September 30, 2016 was $549,244 as compared to $226,472 in the same period in 2015, an increase of $322,772. The increase in depreciation and amortization expense is due to new investments in depreciable assets at our new facility as well as new product tooling costs that took place during the second half of 2015 and for the current 2016 period.

Other Income (Expense). Total other expense was $664,392 for the nine months ended September 30, 2016 compared to an expense of $1,788,401 in the same period in 2015. The $1,124,009 reduction in expenses was primarily the result of a loss of $57,113 on the derivative liability valuation mark-to-market revaluation for the 2016 period versus a loss of $968,467 in the same nine-month period of 2015, and a reduction of $244,488 in senior debt discount and issuance expense amortization for the 2016 period versus 2015, due primarily to ongoing debt conversions.

Provision (Benefit) for Income Taxes. There were no provisions for income taxes for the nine months ended September 30, 2016 or 2015.

Liquidity and Capital Resources

As of September 30, 2016, we had cash and cash equivalents of $5,941,661, a decrease of $5,935,396 from $11,877,058 as of December 31, 2015.

At September 30, 2016 we had current assets of $11,071,515 compared to current liabilities of $4,354,048 which resulted in a positive working capital position of $6,717,467. At December 31, 2015, we had current assets of $16,530,211 compared to current liabilities of $1,802,122 which resulted in a working capital position of $14,728,089. Our current liabilities are comprised principally of accounts payable, accrued expenses and the current portion of convertible debt.

Operating Activities. We used $10,038,160 of cash for operating activities for the nine months ending September 30, 2016 and $8,874,705 in the same period in 2015, primarily the result of an increased operating loss after adding back non-cash items. The major changes in operating assets and liabilities for 2016 resulted from a $623,445 increase in inventories, a $223,135 increase in prepaid expenses, a $206,409 decrease in accounts receivable and a $622,119 increase in accounts payable. The major operating items for the nine-month period ending September 30, 2015 were a $1,122,184 increase in vendor component deposits, a $849,958 increase in inventory and a $281,034 increase in accounts receivable, offset by a $1,785,638 decrease in accounts payable.

Investing Activities. Cash used in investing activities was $1,654,516 for the nine months ending September 30, 2016 as compared to $719,753 in the same period in 2015. During the nine months ending September 30, 2016, $1,551,141 was used primarily for the purchase of fixed assets for our new clean room equipment for our new manufacturing facility as well as additions to product tooling for the M300 and computer equipment additions, as compared to spending of $553,448 for the same period in 2015, primarily for the purchase of manufacturing equipment and mold tooling, as well as computer equipment additions. The costs of registering our intellectual property rights, included in the investing activities totals described above, were $103,375 in the nine-month period ending September 30, 2016 and $166,305 in the same period in 2015.

Financing Activities. We generated $5,757,279 of cash for financing activities for the nine months ending September 30, 2016 as compared to generating $25,581,713 of cash from financing activities in 2015. For the 2016 period, financing activities consisted of a public offering of 1,150,000 shares of common stock, resulting in proceeds after offering expenses of $5,764,695, repayment of $52,416 in notes payable and the receipt of $45,000 from cash warrant exercises. During the nine months ended September 30, 2015, the primary sources of cash from financing activities were the proceeds of $24,813,000 from the sale of Series A Preferred Stock on January 2, 2015 to Intel Corporation, less direct offering costs of $214,169 and the cash proceeds of $1,262,626 from warrant exercises.

Capital Resources. As of September 30, 2016, we had a cash balance of $5,941,661.

The net loss for the nine months ending September 30, 2016 was $12,915,091. The Company incurred annual net losses of $13,427,478 in 2015 and $7,868,858 in 2014, and has an accumulated deficit of $70,503,959 as of September 30, 2016. The Company will need to grow its business significantly to become profitable and self-sustaining on a cash flow basis or it will be required to raise new capital. The Company’s management intends to take actions necessary to continue as a going concern, and accordingly our condensed consolidated financial statements included in this report have been prepared assuming that we will continue as a going concern. This basis of accounting contemplates the recovery of our assets and the satisfaction of liabilities in the normal course of business. These condensed consolidated financial statements do not include any adjustments to the specific amounts and classifications of assets and liabilities, which might be necessary should we be unable to continue as a going concern.

The Company’s cash requirements are primarily for funding operating losses, working capital, research, debt service and capital expenditures. On July 11, 2016, the Company closed its public offering of 1,150,000 shares of common stock, at a public offering price of $5.75 per share. Total net proceeds from the public offering were $5,764,695, after underwriting discounts and commissions and other offering expenses payable by Vuzix. On January 2, 2015 we closed a Series A Preferred Stock sale to Intel Corporation, for an aggregate purchase price of $24,813,000. Our cash requirements related to funding operating losses depend on numerous factors, including new product development activities, our ability to commercialize our products, our products’ timely market acceptance, selling prices and gross margins, and other factors. In order for us to achieve positive cash flow from operations, our product sales will need to significantly increase. In the fourth quarter of 2016, the Company will begin shipping new models and products as compared to its offerings in the prior years. We will also introduce a waveguide based smart glasses product, the M3000 in late spring 2017 that leverages heavily from the M300 design and electronics. However, if these new products are not successful within a reasonable time period, we will have to raise additional capital to maintain operations and/or materially reduce our operating and new product development costs.

Historically, the Company has met its cash needs by borrowings under notes, sales of convertible debt, and the sales of equity. If the Company raises additional funds by these methods, the ownership interest of existing shareholders may be diluted. The amount of such dilution could increase due to the issuance of new warrants or securities with other dilutive characteristics, such as full ratchet anti-dilution clauses or price resets.

In regards to our ongoing capital needs, management intends to limit further growth over the next 4 quarters in our levels of spending on sales and marketing as well as research and development activities. We intend to reduce our attendance at tradeshows in 2017, invest less in tradeshow booths, reduce our spending on external marketing services, as well as curtail any further growth in our sales force until the sales of our new product dictate a compelling need to meet demand. In the area of research and development activities, we intend to reduce reliance on external contractors for engineering and design services over the next year. Fortunately, we will be leveraging much of the prior development work on the M300 up to the waveguide based M3000 smart glasses and as a result we expect that new product’s development costs to be less than half the original M300 smart glasses. Additionally, for the B3000 smart sunglasses, we have already reached a well-designed stage utilizing primarily Vuzix personnel and not the costlier external design services utilized on the M300, and it will soon be ready to commence manufacturing tooling. The B3000 is also based on waveguides and will utilize the same Cobra II projector engines we designed and had built in 2016 for the upcoming M3000 waveguide smart glasses. As a result, we expect the costs and other resources needed to bring these products to market in 2017 will likely be less than our 2016 spending. Further as the costs over the last 12 months to bring our new corporate office and manufacturing facilities up to our requirements has been concluded, we expect our capital spending in these areas to be lower in 2017.

Operationally in 2016, although we are now able to produce high quality iWear Video Headphones, we continue to have component tolerance issues that are reducing yield problems with certain optical components which has limited our overall manufacturing yields. As a result, we have not been able to produce at anywhere near our planned production rates. We have a focused effort on improving the parts yield issues and we have just recently opened a second production line in Asia; as a result, production volumes have been rising. Despite these production challenges we continue to experience solid customer interest in Vuzix iWear and we have finally begun to implement our broader planned marketing and sales activities around iWear, inclusive with a focus on using our iWear as an all-digital and low latency companion product FPV drone and other FPV remote control vehicle users. As we have approximately $1,900,000 in component inventories for iWear, representing approximately 70% of their cost to build around 7,500 units already paid for in our supply chain due to these production issues, we expect to draw down this inventory and convert it into cash with ongoing iWear sales. Such iWear sales will contribute more to our cash flow than just the normal gross margins earned would generate.

The announcement of our new M300 Smart Glasses products slowed our M100 Smart Glasses sales throughout 2016 and has delayed further pilots and roll-outs by many enterprise customers that prefer to employ the latest proven technology. And as there are many improvements offered by the upcoming M300 Smart Glasses, customers have been waiting. The commencement of our promotional package in February 2016 that allowed such customers to easily upgrade their new M100 purchase to an M300 when it is available or place pre-order deposits for the M300 has most of these sales recorded as deferred revenue or deposits, approximately $350,000 as of September 30, 2016. Final engineering verifications and regulatory testing is near complete as of the date of this quarterly report, and we expect volume commercial shipments of the M300 to start taking place before the end of November.

We have thus far not made any real adjustments in the selling prices of our existing M100, but we expect we may do so once the M300 gains strong traction. We had approximately 2,500 M100 Smart Glasses in stock or as work in progress as of September 30, 2016, representing approximately $700,000 in paid for inventory. If the M100 prices are lowered as contemplated, but only to a level where Vuzix still generates positive gross margins, this would allow more price sensitive customers to work with Vuzix smart glasses and see their positive impact on their operations. Many thereafter would be expected to ultimately upgrade to the M300 or M3000 smart glasses in the future.

We are continuing our waveguide development and ramp up for volume production by mid-2017. Positive further strides are being made in waveguide performance, clarity, component materials and tightly controlled replication techniques.

Regarding our new waveguide based products, the M3000 waveguide smart glasses have been released to production engineering for tooling and should commence volume production by summer 2017. We expect to release the Blade 3000, a proposed model name for our first fashion smart sunglasses, by fall of 2017.

We believe our existing cash and cash equivalent balances and reductions in spending on new product releases, along with lower cash requirements for future operations as sales of the new products accelerate, will, if we successfully implement our operating plan, be sufficient to meet our working capital and capital expenditure needs for the foreseeable future even with continued operating losses for the next two quarters. There can, however be no assurance that we will be able to generate positive cash flows from operations in the near future or thereafter.

Forward Looking Statements

This quarterly report includes forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements are based on our management’s beliefs and assumptions and on information currently available to our management. Forward-looking statements include statements concerning:

	·	Our cash needs and financing plans;
	·	Our possible or assumed future results of operations;
	·	Our business strategies;
	·	Our ability to attract and retain customers;
	·	Our ability to sell additional products and services to customers;
	·	Our competitive position;
	·	Our industry environment;
	·	Our potential growth opportunities;
	·	Expected technological advances by us or by third parties and our ability to leverage them;
	·	The effects of future regulation; and
	·	The effects of competition.

All statements in this quarterly report that are not historical facts are forward-looking statements. We may, in some cases, use terms such as “anticipates,” “believes,” “could,” “estimates,” “expects,” “intends,” “may,” “plans,” “potential,” “predicts,” “projects,” “should,” “will,” “would” or similar expressions that convey uncertainty of future events or outcomes to identify forward-looking statements.

The outcome of the events described in these forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performances or achievements expressed or implied by the forward-looking statements.

All such forward-looking statements are subject to certain risks and uncertainties and should be evaluated in light of important risk factors. These risk factors include, but are not limited to, those that are described in “Risk Factors” under Item 1A and elsewhere in our 2015 annual report on Form 10-K and other filings we make with the Securities and Exchange Commission and the following: business and economic conditions, rapid technological changes accompanied by frequent new product introductions, competitive pressures, dependence on key customers, inability to gauge order flows from customers, fluctuations in quarterly and annual results, the reliance on a limited number of third party suppliers, limitations of our manufacturing capacity and arrangements, the protection of our proprietary technology, the effects of pending or threatened litigation, the dependence on key personnel, changes in critical accounting estimates, potential impairments related to investments, foreign regulations, liquidity issues, and potential material weaknesses in internal control over financial reporting. Further, during weak or uncertain economic periods, customers’ may delay the placement of their orders. These factors often result in a substantial portion of our revenue being derived from orders placed within a quarter and shipped in the final month of the same quarter.

Any of these factors could cause our actual results to differ materially from our anticipated results. We caution readers to carefully consider such factors. Many of these factors are beyond our control. In addition, any forward-looking statements represent our estimates only as of the date they are made, and should not be relied upon as representing our estimates as of any subsequent date. While we may elect to update forward-looking statements at some point in the future, except as may be required under applicable securities laws, we specifically disclaim any obligation to do so, even if our estimates change.

Item 3.

Quantitative and Qualitative Disclosures about Market Risk

Not required for a smaller reporting company.

Item 4.

Controls and Procedures

Disclosure Controls and Procedures

We maintain a system of disclosure controls and procedures designed to provide reasonable assurance that information required to be disclosed in reports that we file or submit under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s (SEC) rules and forms. Disclosure controls are also designed to reasonably assure that such information is accumulated and communicated to management, including the Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), as appropriate to allow timely decisions regarding required disclosure. Disclosure controls include components of internal control over financial reporting, which consists of control processes designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements in accordance with GAAP.

As reported in our 2015 Annual Report on Form 10-K (the "2015 Form 10-K"), as of December 31, 2015, our management identified material weaknesses in our internal control over financial reporting that have a direct impact on our financial reporting. Due to these material weaknesses in internal control over financial reporting, our management concluded in our 2015 Form 10-K that our disclosure controls and procedures were ineffective as of December 31, 2015.

Our management, with the participation of our CEO and CFO, has evaluated the effectiveness of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of September 30, 2016. As part of its evaluation, our management has evaluated whether the control deficiencies related to the reported material weaknesses in internal control over financial reporting continue to exist. As of September 30, 2016, we had completed the development, and implemented many of the changes in controls and procedures that we believe are necessary to remediate the material weaknesses. However, we have not completed the assessment and testing of those changes in controls and procedures that we believe are necessary to conclude that the material weaknesses have been remediated and, therefore, our management has concluded that we cannot assert that the control deficiencies relating to the reported material weaknesses have been effectively remediated. As a result, our CEO and CFO have concluded that our disclosure controls and procedures were ineffective as of September 30, 2016.

In light of the foregoing conclusion, we undertook additional procedures in order that management could conclude that reasonable assurance exists regarding the reliability of financial reporting and the preparation of the consolidated financial statements contained in this filing. Accordingly, management believes that our condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for the period ended September 30, 2016 fairly present, in all material respects, our financial position, results of operations and cash flows for the periods presented.

Changes in internal control over financial reporting

Except for the actions described above that were taken to address the material weaknesses, there were no changes in our internal controls during the three months ended September 30, 2016 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Part II. OTHER INFORMATION

Item 1.

Legal Proceedings

We are not involved in any current or pending legal proceeding or litigation and we are not aware of any such proceedings contemplated by or against us or our property. To our knowledge, there are no material legal proceedings to which any our directors, officers or affiliates, or any beneficial owner of more than five percent of our common stock, or any associate of any of the foregoing, is a party adverse to us or any of our subsidiaries or has a material interest adverse to us or any of our subsidiaries.

Item 1A.

Risk Factors

In addition to the other information set forth in this report you should carefully consider the factors discussed in Part I, Item 1A. “Risk Factors” in our annual report on Form 10-K for the year ended December 31, 2015. There have been no material changes from those risk factors. The risks discussed in our 2015 annual report could materially affect our business, financial condition and future results.

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

Sale of Unregistered Securities –

During the three months ended September 30, 2016 we issued 632 shares of common stock upon the cashless exercise of stock options to an employee of the Company.

During the three months ended September 30, 2016, we issued 142,015 shares of common stock upon conversion of convertible notes in the principal amount of $304,500 and $15,035 of accrued interest.

In connection with the foregoing, we relied upon the exemption from registration provided by Section 4(a)(2) under the Securities Act of 1933, as amended, for transactions not involving a public offering.

Purchase of Equity Securities – none

Item 3.

Defaults Upon Senior Securities

None

Item 4.

Mine Safety Disclosures

Not Applicable

Item 5.

Other Information

None

Item 6.

Exhibits

Exhibit No.		Description

31.1		Certification of the Chief Executive Officer of the Registrant pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2		Certification of the Chief Financial Officer of the Registrant pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1		Certification of the Chief Executive Officer of the Registrant pursuant to 18 U.S.C. Section 1350 adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2		Certification of the Chief Financial Officer of the Registrant pursuant to 18 U.S.C. Section 1350 adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS		XBRL Instance Document

101.SCH		XBRL Taxonomy Extension Schema Document

101.CAL		XBRL Taxonomy Extension Calculation Link base Document

101.DEF		XBRL Taxonomy Extension Definition Link base

101.LAB		XBRL Taxonomy Extension Label Link base Document

101.PRE		XBRL Taxonomy Extension Presentation Link base Document

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	VUZIX CORPORATION

Date: November 14, 2016	By:	/s/ Paul J. Travers
		Paul J. Travers
		President, Chief Executive Officer
		(Principal Executive Officer)

Date: November 14, 2016	By:	/s/ Grant Russell
		Grant Russell
		Executive Vice President and Chief Financial Officer
		(Principal Financial and Accounting Officer)

EX-31.1 2 v452286_ex31-1.htm EXHIBIT 31.1

Exhibit 31.1

CERTIFICATION PURSUANT TO SECTION 302

OF THE SARBANES-OXLEY ACT OF 2002

I, Paul J. Travers, certify that:

I have reviewed this quarterly report on Form 10-Q of Vuzix Corporation;

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.

(c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 14, 2016	/s/ Paul J. Travers
	Paul J. Travers
	President and Chief Executive Officer

EX-31.2 3 v452286_ex31-2.htm EXHIBIT 31.2

Exhibit 31.2

CERTIFICATION PURSUANT TO SECTION 302

OF THE SARBANES-OXLEY ACT OF 2002

I, Grant Russell, certify that:

I have reviewed this quarterly report on Form 10-Q of Vuzix Corporation;

(a)

(b)

(c)

(d)

(a)

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 14, 2016	/s/ Grant Russell
	Grant Russell
	Executive Vice President and Chief Financial Officer

EX-32.1 4 v452286_ex32-1.htm EXHIBIT 32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Vuzix Corporation (“Vuzix”) on Form 10-Q for the quarterly period ended September 30, 2016 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Paul J. Travers, President and Chief Executive Officer of Vuzix, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Vuzix.

	/s/ Paul J. Travers
	Paul J. Travers
	President and Chief Executive Officer

Date: November 14, 2016

EX-32.2 5 v452286_ex32-2.htm EXHIBIT 32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Vuzix Corporation (“Vuzix”) on Form 10-Q for the quarterly period ended September 30, 2016 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Grant Russell, Chief Financial Officer of Vuzix, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Vuzix.

	/s/ Grant Russell
	Grant Russell
	Chief Financial Officer

Date: November 14, 2016

EX-101.INS 6 vuzi-20160930.xml XBRL INSTANCE DOCUMENT 0001463972 2014-01-01 2014-12-31 0001463972 2015-01-01 2015-09-30 0001463972 2015-01-01 2015-12-31 0001463972 2016-01-01 2016-09-30 0001463972 2014-06-01 2014-06-03 0001463972 2015-07-01 2015-09-30 0001463972 2016-07-01 2016-07-11 0001463972 2016-07-01 2016-09-30 0001463972 2016-07-11 0001463972 2016-09-30 0001463972 2016-11-14 0001463972 2014-12-31 0001463972 2015-12-31 0001463972 2015-09-30 0001463972 us-gaap:PreferredStockMember 2015-12-31 0001463972 us-gaap:CommonStockMember 2015-12-31 0001463972 us-gaap:RetainedEarningsMember 2015-12-31 0001463972 us-gaap:RetainedEarningsMember 2016-01-01 2016-09-30 0001463972 us-gaap:CommonStockMember 2016-09-30 0001463972 us-gaap:RetainedEarningsMember 2016-09-30 0001463972 us-gaap:AdditionalPaidInCapitalMember 2015-12-31 0001463972 us-gaap:AdditionalPaidInCapitalMember 2016-01-01 2016-09-30 0001463972 us-gaap:AdditionalPaidInCapitalMember 2016-09-30 0001463972 us-gaap:CommonStockMember 2016-01-01 2016-09-30 0001463972 us-gaap:PreferredStockMember 2016-09-30 0001463972 vuzi:CustomerOneMember us-gaap:SalesRevenueGoodsNetMember 2016-01-01 2016-09-30 0001463972 us-gaap:FairValueInputsLevel1Member 2016-09-30 0001463972 us-gaap:FairValueInputsLevel2Member 2016-09-30 0001463972 us-gaap:FairValueInputsLevel3Member 2016-09-30 0001463972 us-gaap:FairValueInputsLevel1Member 2015-12-31 0001463972 us-gaap:FairValueInputsLevel2Member 2015-12-31 0001463972 us-gaap:FairValueInputsLevel3Member 2015-12-31 0001463972 us-gaap:WarrantMember 2016-01-01 2016-09-30 0001463972 us-gaap:WarrantMember 2016-09-30 0001463972 vuzi:MonteCarloOptionsLatticePricingModelWarrantsOutstandingMember 2016-01-01 2016-09-30 0001463972 vuzi:MonteCarloOptionsLatticePricingModelWarrantsOutstandingMember 2015-01-01 2015-12-31 0001463972 vuzi:NotesPayableMember vuzi:GroupThreeMember 2015-12-31 0001463972 vuzi:GroupEightMember 2015-12-31 0001463972 vuzi:NotesPayableMember vuzi:GroupSixMember 2015-12-31 0001463972 vuzi:NotesPayableMember vuzi:GroupThreeMember 2016-09-30 0001463972 vuzi:GroupEightMember 2016-09-30 0001463972 vuzi:NotesPayableMember vuzi:GroupSixMember 2016-09-30 0001463972 vuzi:ConvertibleToSharesOfCompanysCommonStockAt225PerShareSubjectToAdjustmentMember 2016-09-30 0001463972 vuzi:ConvertibleToSharesOfCompanysCommonStockAt225PerShareSubjectToAdjustmentMember 2015-12-31 0001463972 vuzi:UnamortizedDebtDiscountRelatedToDerivativeLiabilityAssociatedWithAboveNotesConversionPriceMember 2016-09-30 0001463972 vuzi:UnamortizedDebtDiscountRelatedToDerivativeLiabilityAssociatedWithAboveNotesConversionPriceMember 2015-12-31 0001463972 vuzi:ConvertibleSeniorSecuredNotesIssuedDebtIssuanceCostsMember 2016-09-30 0001463972 vuzi:ConvertibleSeniorSecuredNotesIssuedDebtIssuanceCostsMember 2015-12-31 0001463972 vuzi:SeniorSecuredConvertibleNoteMember 2016-01-01 2016-09-30 0001463972 us-gaap:SeriesAPreferredStockMember 2016-09-30 0001463972 us-gaap:SeriesAPreferredStockMember us-gaap:CorporationMember 2015-01-01 2015-01-02 0001463972 us-gaap:SeriesAPreferredStockMember us-gaap:CorporationMember 2015-01-02 0001463972 us-gaap:SeriesAPreferredStockMember 2016-01-01 2016-09-30 0001463972 us-gaap:EmployeeStockOptionMember 2015-12-31 0001463972 us-gaap:EmployeeStockOptionMember 2016-01-01 2016-09-30 0001463972 us-gaap:EmployeeStockOptionMember 2016-09-30 0001463972 us-gaap:MinimumMember 2016-01-01 2016-09-30 0001463972 us-gaap:MaximumMember 2016-01-01 2016-09-30 0001463972 vuzi:GroupThreeMember 2016-01-01 2016-09-30 0001463972 vuzi:GroupThreeMember 2015-01-01 2015-12-31 0001463972 vuzi:GroupThreeMember 2016-09-30 0001463972 vuzi:GroupThreeMember 2015-12-31 0001463972 vuzi:GroupTwoMember 2016-01-01 2016-09-30 0001463972 vuzi:GroupTwoMember 2015-01-01 2015-12-31 0001463972 vuzi:GroupTwoMember 2016-09-30 0001463972 vuzi:GroupTwoMember 2015-12-31 0001463972 vuzi:ConvertibleSeniorSecuredNotesPayableMember 2016-09-30 0001463972 vuzi:ConvertibleSeniorSecuredNotesPayableMember 2015-12-31 0001463972 vuzi:ConvertibleSeniorSecuredNotesIssuedDebtIssuanceCostsMember 2014-06-03 0001463972 vuzi:UnamortizedDebtDiscountRelatedToDerivativeLiabilityAssociatedWithNotesMember 2016-01-01 2016-09-30 0001463972 vuzi:UnamortizedDebtDiscountRelatedToDerivativeLiabilityAssociatedWithNotesMember 2015-01-01 2015-12-31 0001463972 vuzi:ConvertibleSeniorSecuredNotesPayableMember 2016-01-01 2016-09-30 0001463972 vuzi:ConvertibleSeniorSecuredNotesPayableMember 2015-01-01 2015-12-31 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure

11877058

5941661

325694

119285

3349098

3972543

608950

832086

2015433

3070452

16530211

11071515

515697

540060

19562629

14968477

907434

1529554

55790

1333709

734497

1053288

7073

23837

1802122

4354048

1227550

160967

1667636

328752

3469758

4682800

19562629

14968477

16088

17478

73665601

80772108

16092871

10285677

-57588868

-70503959

240786

297919

501288

286450

370277

69481

43383

27847

205940 369411

30833

38333

16088

-57588868

16087951

540843

-12915091

17478

-70503959

17478177

73665601

540843

80772108

342034

152

341882

152016

174025

173993

32578

49626

45000 44985 15000 15

40000

241300

241260

1367766

2014015

139500

193331

1507266

2207346

2069964

1590284

39060

77332

2109024

1667616

-601758

539730

5121713

2191624

2627543

1172252

3350441

5079131

549244

226472

-12250699

-8129749

53749

44508

-21267

1335

-664392

-1788401

-12915091

-9918150

-12915091

-9918150

1203693

1121860

-14118784

-11040010

20923

12621

-57133

-968467

101075

118693

-0.86

-0.73

16489522

15207545

582549

890629

79750

582549

970379

819116

612346

31900

819116

644246

-236567

326133

2177957

944426

839497

469443

1274698

1120982

196370

88285

-4725089

-2297003

19124

30443

-13781

287

-310772

-127968

-5035861

-2424971

-5035861

-2424971

410153

386377

-5446014

-2811348

8144

12621

-59120

58239

33981

40956

-0.32

-0.18

17216374

15934279

155313

116008

391334

635949

11707

11708

34867

34740

401863

540843

-968467

-57133

281034

-206409

849958

623445

33579

223135

-1785638

622119

16410

311291

-100016

15536

-25630

16764

67858

-142347

-8874705

-10038160

553448

1551141

166305

103375

-719753

-1654516

16882

150362

52416

25581713

5757279

15987255

-5935397

84967

16072222

21690

7860

1262626

45000

174025

984559

214836

214838

300796

20628

426201

670689

24813000

847805

241300 1669700 898537 0 11543354 -163471 1122184

342034

427500

-112500

0 0 2855463

13427478

7868858

0.14

1150000

5.75

6612500

5764695

3069261

3260075

154880

356407

612451

973348

487494

617287

102792

90316

358719 358719

89000

193196

64002

55511

10000

345546

109984

358719

131687

97801

0.08

28492

29340

55511

58320

49829

45100

0.86

3000000

1938988

297919

240786

57133

297919

P1Y10M6D

1.16

0.0088

P2Y7M6D

1.03

0.0106

59917

-21085

16958

24459

-2109

1591739

1915155

249173 621531

-31207

-66074

1616198

282489

1333709

24459

1591739

323415

143740

18620 8276

5000000

49626

500

24813000

1514081

0.06

2717773

49626

0.001

100000000

17478177

16087951

535091

520091

0 0 15000

2.43

2.37

0 3.00 0 P1Y6M

1022789

60750

1000

31523

1051016

4.59

6.27

2.60

5.58

4.65

569692

4.93

P7Y1M6D

482324

4.34

P7Y

2000000

P1Y7M6D

P7Y

P7Y7M6D

4791846

335248

279373

346039

1388757

92849

371239

65065

2015-10-03

2020-10-03

10-Q false 2016-09-30 2016 Q3 Vuzix Corp 0001463972 --12-31 Smaller Reporting Company VUZI 17560686

7,241,147

7,366,036

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; BACKGROUND: transparent"> <strong><font style="FONT-SIZE: 10pt">Note 4  Accrued Expenses</font></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt 34.55pt"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Accrued expenses consisted of the following:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt 34.55pt"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>September 30, 2016</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>December 31, 2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="75%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>Accrued Wages and Related Costs</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>90,316</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>102,792</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>Accrued Compensation</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>358,719</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>358,719</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>Accrued Professional Services</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>193,196</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>89,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>Accrued Warranty Obligations</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>55,511</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>64,002</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>Accrued Interest</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>345,546</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>109,984</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>Other Accrued Expenses</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>10,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>10,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1,053,288</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>734,497</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt 34.55pt"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">Included in the above accrued compensation are amounts owed to officers of the Company for services rendered that remain outstanding. The amounts were $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">358,719</font></font> as of September 30, 2016 and December 31, 2015. The related interest amounts on the officers’ accrued compensation included in Accrued Interest were $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">131,687</font> and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">97,801</font> respectively as of September 30, 2016 and December 31, 2015. These amounts are not subject to a fixed repayment schedule and they bear interest at a rate of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">8</font>% per year, compounding monthly. The related interest expense amounts for the nine months ended September 30, 2016 and 2015 were $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">28,492</font> and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">29,340</font> respectively. </font></div> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The Company has warranty obligations in connection with the sale of certain of its products. The warranty period for its products is generally one year except in certain European countries where it is two years. The costs incurred to provide for these warranty obligations are estimated and recorded as an accrued liability at the time of sale. The Company estimates its future warranty costs based on product-based historical performance rates and related costs to repair. <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The changes in the Company’s accrued warranty obligations for the nine months ended September 30, 2016 were as follows:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Right; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 95%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="right"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="82%"> <div>Accrued Warranty Obligations at December 31, 2015</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>64,002</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="82%"> <div>Reductions for Settling Warranties</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(58,320)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="82%"> <div>Warranties Issued During Period</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>49,829</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="82%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="82%"> <div>Accrued Warranty Obligations at September 30, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>55,511</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The changes in the Company’s accrued warranty obligations for the nine months ended September 30, 2016 were as follows:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN: 0in 0in 0in 0.5in; WIDTH: 90%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="77%"> <div>Accrued Warranty Obligations at December 31, 2015</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>64,002</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="77%"> <div>Reductions for Settling Warranties</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(58,320)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="77%"> <div>Warranties Issued During Period</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>49,829</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="77%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="77%"> <div>Accrued Warranty Obligations at September 30, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>55,511</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

64002

358719

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><font style="FONT-SIZE: 10pt">Note 5  Derivative Liability and Fair Value Measurements</font></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt; BACKGROUND: transparent"> <strong><font style="FONT-SIZE: 10pt"> </font></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The Company recognized a derivative liability for the warrants to purchase shares of its common stock issued in connection with the equity offering and related debt conversions on August 5, 2013. Those warrants have a cashless exercise provision and an exercise price that is subject to adjustment in the event of subsequent equity sales at a lower purchase price (subject to certain exceptions) along with full-ratchet anti-dilution provisions. In accordance with FASB ASC 815-10-25, we measured the derivative liability using a Monte Carlo Options Lattice pricing model at their issuance date and subsequently remeasured the liability on each reporting date.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt 0.25in"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">Accordingly, at the end of each quarterly reporting date, the derivative fair market value is remeasured and adjusted to current market value. As at September 30, 2016 and December 31, 2015 a total of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 45,100</font></font> warrants were outstanding that contained a full-ratchet anti-dilution provision. In connection with the closing of the Series A Private Placement on January 2, 2015, holders of approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 86</font>% of outstanding warrants issued by the Company in its 2013 public offering and in connection with the conversion by certain holders of the Company’s outstanding debt in connection with the Company’s public offering (collectively, the “Public Offering Warrants”) agreed to irrevocably waive their rights to anti-dilution protection under Section 2(b) of the Public Offering Warrants in the event the Company issues additional securities at a per share price lower than the exercise price of the Public Offering Warrants (the “Public Offering Warrant Waiver”). As a result the related derivative liability was reversed to Nil on January 2, 2015 and reclassified into stockholders equity under Additional Paid-in Capital.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The Company recognized a derivative liability during the year ended December 31, 2014 for the $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">3,000,000</font> of senior convertible notes issued on June 3, 2014, with a conversion price that is subject to adjustment in the event of subsequent equity sales at a lower purchase price (subject to certain exceptions). In accordance with FASB ASC 815-10-25, we measured the derivative liability of this embedded conversion option using a Monte Carlo Options Lattice pricing model at the June 3, 2014 issuance date as $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1,938,988</font>. The value of the derivative liability at issuance was recorded as a discount against the notes in the Long-Term Liabilities section of the balance sheet. Accordingly, at the end of each quarterly reporting date the derivative fair market value is remeasured and adjusted to current market value.</font></div> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">In connection with the closing of the Series A Private Placement on January 2, 2015, each of the holders of notes issued by the Company on June 3, 2014 (the “June 2014 Notes”) agreed to irrevocably waive their rights to anti-dilution protection under Section 5(b) of the June 2014 Notes in the event the Company issues additional securities at a per share price lower than the conversion price of the June 2014 Notes (the “June 2014 Note Waiver”). As a result this derivative liability was reversed to Nil and reclassified into stockholders equity under Additional Paid-in Capital.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt 0.25in"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The Company has adopted FASB ASC Topic 820 for financial instruments measured at fair value on a recurring basis. FASB ASC Topic 820 defines fair value, establishes a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt 0.25in"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. FASB ASC Topic 820 establishes a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt 0.25in"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 0.5in"> <font style="FONT-SIZE: 10pt"> -        Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 0.5in"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 0.5in"> <font style="FONT-SIZE: 10pt"> -        Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 0.5in"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 0.5in"> <font style="FONT-SIZE: 10pt"> -        Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt 22.5pt"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The carrying amount of cash and cash equivalents, accounts receivable, accounts payable, and accrued expenses approximates their fair value due to their short maturity. The carrying amount of notes payable approximates fair value because stated or implied interest rates approximate current interest rates that are available for debt with similar terms.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt 31.5pt"> <strong><font style="FONT-SIZE: 10pt"> </font></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">We measure certain financial instruments at fair value on a recurring basis. <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Assets and liabilities measured at fair value on a recurring basis are as follows at September 30, 2016:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt 4.5pt; BACKGROUND: transparent"> <strong><font style="FONT-SIZE: 10pt"> </font></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Total</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Level 1</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Level 2</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Level 3</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="11%" colspan="2"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="11%" colspan="2"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="11%" colspan="2"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="11%" colspan="2"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Warrant Liability</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>297,919</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>297,919</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Total liabilities measured at fair value (Long-Term)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>297,919</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>297,919</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt 4.5pt; BACKGROUND: transparent"> <strong><font style="FONT-SIZE: 10pt"> </font></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">We measure certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis are as follows at December 31, 2015:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt 4.5pt; BACKGROUND: transparent"> <strong><font style="FONT-SIZE: 10pt"> </font></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Total</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Level 1</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Level 2</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Level 3</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Warrant Liability</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>240,786</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>240,786</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Total liabilities measured at fair value (Long-Term)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>240,786</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>240,786</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt 4.5pt; BACKGROUND: transparent"> <font style="FONT-SIZE: 10pt"> </font></div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 88%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>Fair value  December 31, 2015</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>240,786</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>Change in fair value for the period of warrant derivative liability</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>57,133</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>Fair value  September 30, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>297,919</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt 4.5pt; BACKGROUND: transparent" align="center"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The Monte Carlo Options Lattice pricing model was used to estimate the fair value of the warrants outstanding:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt 4.5pt; BACKGROUND: transparent" align="center"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both" align="center"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="74%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>September 30,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>December 31,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="74%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2016</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700; TEXT-DECORATION: underline" width="74%"> <div>Assumptions for Pricing Model:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="74%"> <div>Expected term in years</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1.85</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2.60</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="74%"> <div>Volatility</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>116</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>103</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="74%"> <div>Risk-free interest rate</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>0.88</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1.06</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="74%"> <div>Expected annual dividends</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>None</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>None</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> </div> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">Fluctuations in the variables used in calculating the value of the Company’s derivative liability could have a significant impact on the resulting valuation.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">Assets and liabilities measured at fair value on a recurring basis are as follows at September 30, 2016:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt 4.5pt; BACKGROUND: transparent"> <strong><font style="FONT-SIZE: 10pt"> </font></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Total</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Level 1</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Level 2</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Level 3</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="11%" colspan="2"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="11%" colspan="2"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="11%" colspan="2"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="11%" colspan="2"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Warrant Liability</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>297,919</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>297,919</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Total liabilities measured at fair value (Long-Term)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>297,919</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>297,919</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt 4.5pt; BACKGROUND: transparent"> <strong><font style="FONT-SIZE: 10pt"> </font></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">We measure certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis are as follows at December 31, 2015:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt 4.5pt; BACKGROUND: transparent"> <strong><font style="FONT-SIZE: 10pt"> </font></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Total</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Level 1</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Level 2</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Level 3</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Warrant Liability</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>240,786</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>240,786</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Total liabilities measured at fair value (Long-Term)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>240,786</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>240,786</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

240786

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; BACKGROUND: transparent"> <strong><font style="FONT-SIZE: 10pt">Note 6  Long-Term Debt</font></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt 0.5in"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Long-term debt consisted of the following:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt 0.25in; BACKGROUND: transparent"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both">September 30,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both">December 31,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both">2016</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both">2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div style="CLEAR:both;TEXT-INDENT: -13px; MARGIN-LEFT: 13px">Note payable for research and development equipment. The principal is subject to a fixed semi-annual repayment schedule commencing October 31, 2013 over 48 months. The note carries a 0% interest rate.</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">24,459</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">59,917</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div style="CLEAR:both;TEXT-INDENT: -13px; MARGIN-LEFT: 13px">The note carries a 0% interest rate, but imputed interest has been accrued based on a 12% discount rate and is reflected as a reduction in the principal.</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">(2,109)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">(21,085)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div style="CLEAR:both;TEXT-INDENT: -13px; MARGIN-LEFT: 13px">Note payable for which the principal and interest is subject to a fixed blended repayment schedule of 36 months, commencing July 15, 2013. The loan bears interest at 12% per year and is secured by a subordinated position in all the assets of the Company.</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both"></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">16,958</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div style="CLEAR:both;TEXT-INDENT: -13px; MARGIN-LEFT: 13px"> Convertible, Senior Secured Notes payable. The principal is due June 3, 2017 and no principal payments are required prior to maturity. The notes carry a 5% interest rate, payable upon the notes’ maturities. Both the principal plus accrued interest is convertible into shares of the Company’s common stock at $2.25 per share, subject to normal adjustments. The notes are secured by a first security position in all the assets of the Company.</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">1,591,739</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">1,915,155</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div style="CLEAR:both;TEXT-INDENT: -13px; MARGIN-LEFT: 13px"> Convertible, Senior Secured Notes Payable Issuance Costs of $139,340, net of accumulated amortization. The estimated aggregate amortization expense is approximately $11,000 for the remainder of fiscal 2016 and approximately $20,000 in the following fiscal year.</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">(31,207)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">(66,074)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div style="CLEAR:both;TEXT-INDENT: -13px; MARGIN-LEFT: 13px"> Unamortized debt discount related to derivative liability associated with above notes’ conversion price that was subject to adjustment in the event of subsequent equity sales at a lower purchase price (subject to certain exceptions). Upon issuance on June 3, 2014 the discount was $1,938,988.</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">(249,173)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">(621,531)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">1,333,709</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">1,283,340</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 10px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div style="CLEAR:both;CLEAR: both">Less: Amount Due Within One Year</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">(1,333,709)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">(55,790)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 10px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div style="CLEAR:both;CLEAR: both">Amount Due After One Year</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both"></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">1,227,550</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> </table> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The calendar year aggregate maturities for all long-term debt exclusive of discounts as of September 30, 2016 are as follows:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both" align="center"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 85%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0"> <tr style="HEIGHT: 12px"> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="72%"> <div style="CLEAR:both;CLEAR: both"> Total Aggregate Maturity For Period</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both">Amounts</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="72%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="72%"> <div style="CLEAR:both;CLEAR: both">2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">24,459</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="72%"> <div style="CLEAR:both;CLEAR: both">2017</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">1,591,739</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="72%"> <div style="CLEAR:both;CLEAR: both">Total Required Principal Payments Exclusive of Debt Discounts</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">1,616,198</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="72%"> <div style="CLEAR:both;CLEAR: both">Total Unamortized Debt Discounts and Deferred Costs</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">(282,489)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="72%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="72%"> <div style="CLEAR:both;CLEAR: both">Total Net Long-Term Borrowings as of September 30, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">1,333,709</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> </table> </div> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt 34.55pt; BACKGROUND: transparent"> <strong><font style="FONT-SIZE: 10pt"> </font></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">Of the Convertible, Senior Secured Notes, a total of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">323,415</font> were converted into <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 143,740</font> shares of common stock and a total of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">18,620</font> of accrued interest on these Notes were converted into <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 8,276</font> shares of common stock during the nine months ended September 30, 2016. As a result of conversion, $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">47,811</font> of unamortized discounts were written off and included in Amortization of Senior Term Debt Discount for the nine months ended September 30, 2016.  </font></div> </div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt 0.5in"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">Long-term debt consisted of the following:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt 0.25in; BACKGROUND: transparent"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both">September 30,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both">December 31,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both">2016</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both">2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div style="CLEAR:both;TEXT-INDENT: -13px; MARGIN-LEFT: 13px">Note payable for research and development equipment. The principal is subject to a fixed semi-annual repayment schedule commencing October 31, 2013 over 48 months. The note carries a 0% interest rate.</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">24,459</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">59,917</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div style="CLEAR:both;TEXT-INDENT: -13px; MARGIN-LEFT: 13px">The note carries a 0% interest rate, but imputed interest has been accrued based on a 12% discount rate and is reflected as a reduction in the principal.</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">(2,109)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">(21,085)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div style="CLEAR:both;TEXT-INDENT: -13px; MARGIN-LEFT: 13px">Note payable for which the principal and interest is subject to a fixed blended repayment schedule of 36 months, commencing July 15, 2013. The loan bears interest at 12% per year and is secured by a subordinated position in all the assets of the Company.</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both"></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">16,958</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div style="CLEAR:both;TEXT-INDENT: -13px; MARGIN-LEFT: 13px"> Convertible, Senior Secured Notes payable. The principal is due June 3, 2017 and no principal payments are required prior to maturity. The notes carry a 5% interest rate, payable upon the notes’ maturities. Both the principal plus accrued interest is convertible into shares of the Company’s common stock at $2.25 per share, subject to normal adjustments. The notes are secured by a first security position in all the assets of the Company.</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">1,591,739</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">1,915,155</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div style="CLEAR:both;TEXT-INDENT: -13px; MARGIN-LEFT: 13px"> Convertible, Senior Secured Notes Payable Issuance Costs of $139,340, net of accumulated amortization. The estimated aggregate amortization expense is approximately $11,000 for the remainder of fiscal 2016 and approximately $20,000 in the following fiscal year.</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">(31,207)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">(66,074)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div style="CLEAR:both;TEXT-INDENT: -13px; MARGIN-LEFT: 13px"> Unamortized debt discount related to derivative liability associated with above notes’ conversion price that was subject to adjustment in the event of subsequent equity sales at a lower purchase price (subject to certain exceptions). Upon issuance on June 3, 2014 the discount was $1,938,988.</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">(249,173)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">(621,531)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">1,333,709</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">1,283,340</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 10px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div style="CLEAR:both;CLEAR: both">Less: Amount Due Within One Year</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">(1,333,709)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">(55,790)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 10px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div style="CLEAR:both;CLEAR: both">Amount Due After One Year</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both"></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">1,227,550</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

1283340

Each share of Series A Preferred Stock is convertible, at the option of the Series A holder, into 100 shares of the Companys common stock (determined by dividing the Series A Original Issue Price of $500 by the Series A Conversion Price. The Series A Conversion Price is $5.00, subject to adjustment in the event of stock splits, dividends or other combinations

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt 34.55pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">A summary of the various changes in warrants during the nine-month period ended September 30, 2016 is as follows:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt; BACKGROUND: transparent"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both" align="center"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 80%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both">Weighted</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both">Average</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both">Number of</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both">Exercise</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both">Shares</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both">Price</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: calibri; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="55%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: calibri; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: calibri; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: calibri; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: calibri; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: calibri; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: calibri; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: calibri; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div style="CLEAR:both;CLEAR: both">Outstanding at December 31, 2015</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">535,091</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">2.43</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div style="CLEAR:both;CLEAR: both">Issued During the Period</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both"></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both"></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div style="CLEAR:both;CLEAR: both">Exercised During the Period</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">(15,000)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">3.00</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div style="CLEAR:both;CLEAR: both">Expired During the Period</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both"></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both"></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div style="CLEAR:both;CLEAR: both">Outstanding at September 30, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">520,091</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">2.37</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> </table> </div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; BACKGROUND: transparent"> <strong><font style="FONT-SIZE: 10pt">Note 10  Stock Option Plans</font></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt 34.55pt"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">A<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> summary of stock option activity for the nine months ended September 30, 2016 is as follows:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 20pt; MARGIN: 0in 0in 0pt 34.55pt; BACKGROUND: transparent"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both" align="center"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 80%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both">Weighted</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both">Average</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both">Number of</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both">Exercise</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both">Shares</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both">Price</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: calibri; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="55%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: calibri; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: calibri; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: calibri; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: calibri; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: calibri; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: calibri; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: calibri; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div style="CLEAR:both;CLEAR: both">Outstanding at December 31, 2015</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">1,022,789</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">4.59</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div style="CLEAR:both;CLEAR: both">Granted</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">60,750</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">6.27</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div style="CLEAR:both;CLEAR: both">Exercised</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">(1,000)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">2.60</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div style="CLEAR:both;CLEAR: both">Expired or Forfeited</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">(31,523)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">5.58</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div style="CLEAR:both;CLEAR: both">Outstanding at September 30, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">1,051,016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">4.65</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> </table> </div> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 20pt; MARGIN: 0in 0in 0pt 34.55pt; BACKGROUND: transparent"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"><font style="FONT-SIZE: 10pt"> </font><font style="FONT-SIZE: 10pt"></font></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The weighted average remaining contractual term for all options as of September 30, 2016 and December 31, 2015 was <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 7.0</font> years and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 7.6</font> years respectively.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 20pt; MARGIN: 0in 0in 0pt 34.55pt; BACKGROUND: transparent"> <font style="FONT-SIZE: 10pt"><font style="FONT-SIZE: 10pt"> </font> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">As of September 30, 2016, there were <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 569,692</font> options that were fully vested and exercisable at a weighted average exercise price of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">4.93</font> per share. The weighted average remaining contractual term on the vested options is <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 7.1</font> years.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt 34.55pt"> <font style="FONT-SIZE: 10pt">  </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">As of September 30, 2016 there were <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 482,324</font> unvested options exercisable at a weighted average exercise price of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">4.34</font> per share. The weighted average remaining contractual term on the unvested options is <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 7.0</font> years.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 20pt; MARGIN: 0in 0in 0pt 34.55pt; BACKGROUND: transparent"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">No options were exercised for cash during the nine months ended September 30, 2016 and 2015. There were <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 1,000</font></font></font> options exercised on a cashless basis during the three months ended September 30, 2016.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt 34.55pt"> <font style="FONT-SIZE: 10pt">  </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The weighted average fair value of option grants was calculated using the Black-Scholes-Merton option pricing method. At September 30, 2016, the Company had approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2</font> million of unrecognized stock compensation expense, which will be recognized over a weighted average period of approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 1.6</font> years.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 20pt; MARGIN: 0in 0in 0pt 34.55pt; BACKGROUND: transparent"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The aggregate intrinsic value that would have been received by the option holders had all holders exercised their options on September 30, 2016 was $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">4,791,846</font>. The value represents the total pre-tax intrinsic value (the difference between the Company’s closing stock price on the last trading day of the third quarter of fiscal year 2016 and the exercise price, multiplied by the number of in-the-money stock options). The amount of this aggregate intrinsic value will change based on the fair market value of the Company’s stock.</font></div> <font style="FONT-SIZE: 10pt"> </font></div> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The following summary table shows the assumptions used to the fair value of options granted during the nine-month period ended September 30, 2016 and their estimated value:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 20pt; MARGIN: 0in 0in 0pt 34.55pt; BACKGROUND: transparent"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both" align="center"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 80%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="67%"> <div style="CLEAR:both;CLEAR: both">• Expected term in years</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both">7.9 years</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="67%"> <div style="CLEAR:both;CLEAR: both">• Volatility</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both">107.2 - 109.7</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">%</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="67%"> <div style="CLEAR:both;CLEAR: both">• Risk-free interest rate</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">1.28 - 1.68</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">%</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="67%"> <div style="CLEAR:both;CLEAR: both">• Expected annual dividends</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 2px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">None</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="67%"> <div style="CLEAR:both;CLEAR: both">• Fair value of options issued</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">333,434</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> </table> </div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">summary of stock option activity for the nine months ended September 30, 2016 is as follows:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 20pt; MARGIN: 0in 0in 0pt 34.55pt; BACKGROUND: transparent"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both" align="center"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 80%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both">Weighted</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both">Average</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both">Number of</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both">Exercise</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both">Shares</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both">Price</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: calibri; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="55%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: calibri; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: calibri; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: calibri; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: calibri; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: calibri; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: calibri; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: calibri; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div style="CLEAR:both;CLEAR: both">Outstanding at December 31, 2015</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">1,022,789</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">4.59</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div style="CLEAR:both;CLEAR: both">Granted</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">60,750</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">6.27</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div style="CLEAR:both;CLEAR: both">Exercised</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">(1,000)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">2.60</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div style="CLEAR:both;CLEAR: both">Expired or Forfeited</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">(31,523)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">5.58</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div style="CLEAR:both;CLEAR: both">Outstanding at September 30, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">1,051,016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">4.65</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> </table> </div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

333434

P7Y10M24D

1.072

1.097

0.0128

0.0168

48 months

0.00

36 months

0.1200

0.0500

2.25

139340

1938988 1938988

11000

20000

-25890

6612500

1150

6611350

1150000

847805

632

6612500

214169

2013-10-31

2017-06-03

2013-07-15

45100

1000

-1

-25890

47811

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"> <b><font style="FONT-SIZE: 10pt">Note 13  Recent Accounting Pronouncements</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt 0.5in; size: 8.5in 11.0in"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; size: 8.5in 11.0in"> In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers, an updated standard on revenue recognition. The ASU will supersede most of the existing revenue recognition requirements in GAAP and will require entities to recognize revenue at an amount that reflects the consideration to which a company expects to be entitled in exchange for transferring goods or services to a customer. This ASU also amends the required disclosures of the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. The guidance is effective for annual periods beginning after December 15, 2017, including interim periods within that period. Early adoption is permitted for annual periods beginning after December 15, 2016. The Company is determining its implementation approach and evaluating the potential impacts of the new standard on its existing revenue recognition policies and procedures.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"> <font style="FONT-SIZE: 10pt"><font style="BACKGROUND-COLOR: transparent"> </font></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"> <font style="BACKGROUND: none transparent scroll repeat 0% 0%; FONT-SIZE: 10pt"> In August 2014, the FASB issued ASU 2014-15, “Presentation of Financial Statements  Going Concern”, which provides guidance on determining when and how to disclose going-concern uncertainties in the financial statements. The new standard requires management to perform interim and annual assessments of an entity’s ability to continue as a going concern within one year of the date the financial statements are issued. An entity will be required to provide certain disclosures if conditions or events raise substantial doubt about the entity’s ability to continue as a going concern. The ASU applies to all entities and is effective for annual periods ending after December 15, 2016, and interim periods thereafter, with early adoption permitted. We are currently evaluating the impact of the adoption of ASU 2014-15 on our consolidated financial statements and have not yet determined when we will adopt the standard.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt 0.5in; size: 8.5in 11.0in"> <font style="FONT-SIZE: 10pt"><font style="BACKGROUND-COLOR: transparent"> </font></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; size: 8.5in 11.0in"> In July 2015, the FASB issued ASU 2015-11, “Inventory  Simplifying the Measurement of Inventory” which requires inventory within the scope of the standard to be measured at the lower of cost and net realizable value. Previous guidance required inventory to be measured at the lower of cost or market (where market was defined as replacement cost, with a ceiling of net realizable value and floor of net realizable value less a normal profit margin). The updated guidance is effective for interim and annual reporting periods beginning after December 15, 2016, with early adoption permitted. The Company is currently evaluating the impact, if any, the adoption of this standard will have on the consolidated financial statements.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"> <font style="FONT-SIZE: 10pt"><font style="BACKGROUND-COLOR: transparent"> </font></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; size: 8.5in 11.0in"> In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842). Current U.S. generally accepted accounting principles (GAAP) requires lessees and lessors to classify leases as either capital leases or operating leases. Lessees recognize assets and liabilities for capital leases but do not recognize assets and liabilities for operating leases. ASU 2016-02 requires lessees to recognize assets and liabilities for all leases (with an exception for short-term leases). The new FASB guidance will be effective for fiscal years beginning after December 15, 2018, and interim periods thereafter. The Company is currently evaluating the impact, if any, the adoption of this standard will have on the consolidated financial statements.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"> <font style="FONT-SIZE: 10pt"><font style="BACKGROUND-COLOR: transparent"> </font></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; size: 8.5in 11.0in"> In March 2016, the FASB issued ASU No. 2016-09, “Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting,” which amends the current stock compensation guidance. The amendments simplify the accounting for the taxes related to stock based compensation, including adjustments to how excess tax benefits and a company's payments for tax withholdings should be classified. The standard is effective for fiscal periods beginning after December 15, 2016, with early adoption permitted. The Company is evaluating the impact, if any, the adoption of this standard will have on the consolidated financial statements and related disclosures.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"> <font style="FONT-SIZE: 10pt"><font style="BACKGROUND-COLOR: transparent"> </font></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; size: 8.5in 11.0in"> In April 2016, the FASB issued ASU No. 2016-10, “Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing” to clarify two aspects of Topic 606: (i) identifying performance obligations and (ii) the licensing implementation guidance, while retaining the related principles for those areas. The Company is evaluating the impact, if any, the adoption of this standard will have on the consolidated financial statements and related disclosures.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"> <font style="FONT-SIZE: 10pt"></font> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> In May 2016, the FASB issued ASU No. 2016-12, “Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients” in an effort to reduce (i) the potential for diversity at initial application and (ii) the cost and complexity of applying Topic 606 both at transition and on an ongoing basis. The Company is evaluating the impact, if any, the adoption of this standard will have on the consolidated financial statements and related disclosures.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> In August 2016, the FASB issued ASU 2016-15, “Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments (a Consensus of the Emerging Issues Task Force)” in an effort to reduce existing diversity in practice related to the classification of certain cash receipts and cash payments on the statements of cash flows. The guidance addresses the classification of cash flows related to, among other things, distributions received from equity method investees. The amendments in this update are effective for annual periods beginning after December 15, 2017, and interim periods within those annual periods. The Company has not yet completed its assessment of the impact that the adoption of ASU 2016-15 will have on its consolidated financial statements. </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"> <font style="FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> There are no other recent accounting pronouncements that are expected to have a material impact on the condensed consolidated financial statements.</div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

EX-101.SCH 7 vuzi-20160930.xsd XBRL TAXONOMY EXTENSION SCHEMA 101 - Document - Document And Entity Information link:presentationLink link:definitionLink link:calculationLink 102 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:definitionLink link:calculationLink 103 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY link:presentationLink link:definitionLink link:calculationLink 104 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS link:presentationLink link:definitionLink link:calculationLink 105 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:definitionLink link:calculationLink 106 - Disclosure - Basis of Presentation link:presentationLink link:definitionLink link:calculationLink 107 - Disclosure - Loss Per Share link:presentationLink link:definitionLink link:calculationLink 108 - Disclosure - Inventories, Net link:presentationLink link:definitionLink link:calculationLink 109 - Disclosure - Accrued Expenses link:presentationLink link:definitionLink link:calculationLink 110 - Disclosure - Derivative Liability and Fair Value Measurements link:presentationLink link:definitionLink link:calculationLink 111 - Disclosure - Long-Term Debt link:presentationLink link:definitionLink link:calculationLink 112 - Disclosure - Income Taxes link:presentationLink link:definitionLink link:calculationLink 113 - Disclosure - Capital Stock link:presentationLink link:definitionLink link:calculationLink 114 - Disclosure - Stock Warrants link:presentationLink link:definitionLink link:calculationLink 115 - Disclosure - Stock Option Plans link:presentationLink link:definitionLink link:calculationLink 116 - Disclosure - Litigation link:presentationLink link:definitionLink link:calculationLink 117 - Disclosure - Contractual Obligations link:presentationLink link:definitionLink link:calculationLink 118 - Disclosure - Recent Accounting Pronouncements link:presentationLink link:definitionLink link:calculationLink 119 - Disclosure - Inventories, Net (Tables) link:presentationLink link:definitionLink link:calculationLink 120 - Disclosure - Accrued Expenses (Tables) link:presentationLink link:definitionLink link:calculationLink 121 - Disclosure - Derivative Liability and Fair Value Measurements (Tables) link:presentationLink link:definitionLink link:calculationLink 122 - Disclosure - Long-Term Debt (Tables) link:presentationLink link:definitionLink link:calculationLink 123 - Disclosure - Stock Warrants (Tables) link:presentationLink link:definitionLink link:calculationLink 124 - Disclosure - Stock Option Plans (Tables) link:presentationLink link:definitionLink link:calculationLink 125 - Disclosure - Contractual Obligations (Tables) link:presentationLink link:definitionLink link:calculationLink 126 - Disclosure - Basis of Presentation (Additional Information) (Detail) link:presentationLink link:definitionLink link:calculationLink 127 - Disclosure - Loss Per Share (Additional Information) (Detail) link:presentationLink link:definitionLink link:calculationLink 128 - Disclosure - Inventories, Net (Components of Inventories) (Detail) link:presentationLink link:definitionLink link:calculationLink 129 - Disclosure - Accrued Expenses (Components of Accrued Expenses) (Detail) link:presentationLink link:definitionLink link:calculationLink 130 - Disclosure - Accrued Expenses (Changes in Accrued Warranty Obligations) (Detail) link:presentationLink link:definitionLink link:calculationLink 131 - Disclosure - Accrued Expenses - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 132 - Disclosure - Derivative Liability and Fair Value Measurements (Schedule of Assets And Liabilities Measured At Fair Value On A Recurring Basis) (Detail) link:presentationLink link:definitionLink link:calculationLink 133 - Disclosure - Derivative Liability and Fair Value Measurements (Schedule of Fair Value Level 3 Warrant Liabilities) (Detail) link:presentationLink link:definitionLink link:calculationLink 134 - Disclosure - Derivative Liability and Fair Value Measurements (Estimate the fair value of warrants outstanding) (Detail) link:presentationLink link:definitionLink link:calculationLink 135 - Disclosure - Derivative Liability and Fair Value Measurements (Additional Information) (Detail) link:presentationLink link:definitionLink link:calculationLink 136 - Disclosure - Long-Term Debt (Components of Long-Term Debt) (Detail) link:presentationLink link:definitionLink link:calculationLink 137 - Disclosure - Long-Term Debt (Components of Long-Term Debt) (Parenthetical) (Detail) link:presentationLink link:definitionLink link:calculationLink 138 - Disclosure - Long-Term Debt (Aggregate Maturities For All Long Term Borrowings) (Detail) link:presentationLink link:definitionLink link:calculationLink 139 - Disclosure - Long-Term Debt (Additional Information) (Detail) link:presentationLink link:definitionLink link:calculationLink 140 - Disclosure - Capital Stock (Additional Information) (Detail) link:presentationLink link:definitionLink link:calculationLink 141 - Disclosure - Stock Warrants (Changes in Warrants) (Detail) link:presentationLink link:definitionLink link:calculationLink 142 - Disclosure - Stock Warrants (Additional Information) (Detail) link:presentationLink link:definitionLink link:calculationLink 143 - Disclosure - Stock Option Plans (Summary of Stock Option Activity) (Detail) link:presentationLink link:definitionLink link:calculationLink 144 - Disclosure - Stock Option Plans (Assumptions Used To Compute The Fair Value Of Stock Options) (Detail) link:presentationLink link:definitionLink link:calculationLink 145 - Disclosure - Stock Option Plans (Additional Information) (Detail) link:presentationLink link:definitionLink link:calculationLink 146 - Disclosure - Contractual Obligations (Future Minimum Payments Required Under Operating Lease) (Detail) link:presentationLink link:definitionLink link:calculationLink 147 - Disclosure - Contractual Obligations (Additional Information) (Detail) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 8 vuzi-20160930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 9 vuzi-20160930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 10 vuzi-20160930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Document And Entity Information [Abstract] Document Information [Table] Class of Stock [Axis] Statement Of Financial Position [Abstract] Statement [Table] Legal Entity [Axis] Entity [Domain] Statement [Line Items] Assets Current [Abstract] Current Assets Cash and Cash Equivalents, at Carrying Value Cash and Cash Equivalents Cash and Cash Equivalents - Beginning of Period Cash and Cash Equivalents - End of Period Accounts Receivable, Net, Current Accounts Receivable Net Inventory, Net Inventories, Net Net Prepaid Manufacturing Vendor Payments Manufacturing Vendor Prepayments Amount of consideration paid in advance for manufacturing vendor that provide economic benefits within a future period of one year or the normal operating cycle, if longer. Property, Plant and Equipment, Net Fixed Assets, Net Net Intangible Assets, Net (Excluding Goodwill) Patents and Trademarks, Net Capitalized Computer Software, Net, Total Software Development Costs, Net Net Accounts Payable Current Accounts Payable Long-term Debt, Current Maturities, Total Current Portion of Long-Term Debt, net of discount Less: Amount Due Within One Year Customer Deposits Current Customer Deposits Deferred Revenue, Current Unearned Revenue Accrued Liabilities Current Accrued Expenses Total Accrued Income Taxes Current Income and Other Taxes Payable Assets Total Assets Derivative Liability, Noncurrent Long-Term Derivative Liability Long-term Debt, Excluding Current Maturities, Total Long-Term Portion of Term Debt, net of discount Amount Due After One Year Accounts Payable and Accrued Liabilities, Noncurrent Long-Term Portion of Accrued Expenses Other Accrued Liabilities, Noncurrent Long-Term Portion of Accrued Interest Liabilities Current [Abstract] Current Liabilities Liabilities Noncurrent [Abstract] Long-Term Liabilities Preferred Stock Value Preferred Stock Common Stock Value Common Stock Additional Paid In Capital Additional Paid-in Capital Retained Earnings Accumulated Deficit Accumulated Deficit Accumulated (Deficit) Stockholders' Equity Attributable To Parent Total Stockholders' Equity Balance Balance Liabilities, Total Total Liabilities Statement Of Stockholders' Equity [Abstract] Equity Components [Axis] Equity Component [Domain] Preferred Stock [Member] Preferred Stock Common Stock [Member] Common Stock Additional Paid-In Capital [Member] Additional Paid-in Capital Retained Earnings [Member] Accumulated Deficit Exercise Of Stock Option [Axis] Exercise Of Stock Option [Domain] Shares, Outstanding Balance (in shares) Balance (in shares) Income Statement [Abstract] Sales Revenue Goods Net Sales of Products Sales Revenue Services Net Sales of Engineering Services Sales Revenue Net Total Sales Cost Of Goods Sold Cost of Sales - Products Cost Of Services Cost of Sales - Engineering Services Cost Of Revenue Total Cost of Sales Gross Profit Gross Profit (Loss) (exclusive of depreciation shown separately below) Operating Expenses [Abstract] Operating Expenses: Research and Development Expense Research and Development Selling and Marketing Expense Selling and Marketing General and Administrative Expense General and Administrative Depreciation and Amortization Depreciation and Amortization Investment Income, Interest Interest Income Nonoperating Income Expense [Abstract] Other Income (Expense) Taxes, Other Other Taxes Foreign Currency Transaction Gain Loss Before Tax Foreign Exchange (Loss) Gain Gain (Loss) on Derivative Instruments, Net, Pretax Gain (Loss) on Derivative Valuation Gain (Loss) on Disposition of Assets (Loss) on Fixed Asset Disposal Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Loss Before Income Taxes Income Tax Expense (Benefit) Provision (Benefit) for Income Taxes Total Provision Net Income (Loss) Attributable To Parent Net Loss Net Loss Net Loss (B) Net Loss for the Nine months ended September 30, 2016 Preferred Stock Dividends and Other Adjustments Preferred Stock Dividends Net Income (Loss) Available to Common Stockholders, Basic Loss Attributable to Common Stockholders Statement Of Cash Flows [Abstract] Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract] Cash Flows from Operating Activities Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract] Non-Cash Adjustments Capitalized Computer Software, Amortization Amortization of Software Development Costs in Cost of Sales products Gain (Loss) on Disposition of Property Plant Equipment, Total Loss on Disposal of Fixed Assets Loss on Sale of Assets Common Stock Awards Compensation Expense Common Stock Awards Compensation Expense It represents the common stock awards compensation expense during the reporting period. Increase Decrease In Accounts Receivable Accounts Receivable Increase Decrease In Inventories Inventories Increase decrease in vendors prepayments Manufacturing Vendor Prepayments Amount of increase (decrease) of consideration paid in advance for vendors payments that provide economic benefits in future periods. Share-Based Compensation Stock Based Option Compensation Expense Stock Options Increase Decrease In Accounts Payable Accounts Payable Increase Decrease In Accrued Liabilities Accrued Expense Increase Decrease In Customer Deposits Customer Deposits Increase (Decrease) in Deferred Revenue Unearned Revenue Increase Decrease In Accrued Income Taxes Payable Income and Other Taxes Payable Net Cash Provided by (Used in) Operating Activities, Continuing Operations Net Cash Flows Used in Operating Activities Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract] Cash Flows from Investing Activities Payments To Acquire Property Plant and Equipment Purchases of Fixed Assets Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract] Cash Flows from Financing Activities Proceeds from Warrant Exercises Proceeds from Exercise of Warrants Exercise of Stock Warrants Repayments Of Long Term Capital Lease Obligations Repayment of Capital Leases Repayments Of Long Term Debt Repayment of Long-Term Debt and Notes Payable Repayment of Convertible, Senior Secured Term Debt Loan Proceeds from Issuance of Common Stock Proceeds from Public Offering Payments of Debt Issuance Costs Issuance Costs of Public Offering Proceeds from Issuance of Preferred Stock and Preference Stock Proceeds from Preferred Stock Offering Payments of Stock Issuance Costs Issuance Costs of Preferred Stock Offering Direct Offering Associated Costs Cash and Cash Equivalents Period Increase Decrease Net (Decrease) Increase in Cash and Cash Equivalents Supplemental Cash Flow Information [Abstract] Supplemental Disclosures Interest Paid Interest Paid in Cash Common Stock Issued and Warrant Issued For Services Prepaid Expense Common Stock and Warrants Issued for Services The amount of common stock issued for services during the period, classified as prepaid expense. Cash Flow Noncash Investing and Financing Activities Disclosure [Abstract] Non-Cash Investing Activities Noncash Financing Activities [Abstract] Non-Cash Financing Activities Organization, Consolidation and Presentation Of Financial Statements [Abstract] Basis Of Accounting Basis of Presentation Earnings Per Share [Abstract] Earnings (Loss) Per Share [Abstract] Loss Per Share Per share decrease in Income or increase in Loss Per Share: Earnings Per Share [Text Block] Loss Per Share Inventory Disclosure [Abstract] Inventory Disclosure [Text Block] Inventories,Net Payables and Accruals [Abstract] Accounts Payable and Accrued Liabilities Disclosure [Text Block] Accrued Expenses Debt Disclosure [Abstract] Long Term Debt [Text Block] Long-Term Debt Income Tax Disclosure [Abstract] Income Tax Disclosure [Text Block] Income Taxes Stockholders' Equity Note [Abstract] Stockholders' Equity Note Disclosure [Text Block] Capital Stock Stock Warrants [Text Block] Stock Warrants The entire disclosure for stock warrants. Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Stock Option Plans Litigation Disclosure [Abstract] Legal Matters and Contingencies [Text Block] Litigation Schedule Of Inventory, Current [Table Text Block] Schedule of Inventories Schedule Of Accrued Liabilities Table [Text Block] Components of Accrued Expenses Schedule Of Product Warranty Liability Table [Text Block] Changes in Accrued Warranty Obligations Schedule Of Debt Instruments [Text Block] Components of Long-Term Debt Schedule Of Maturities Of Long-Term Debt [Table Text Block] Aggregate maturities for all long-term borrowings Schedule Of Stockholders Equity Note Warrants Or Rights [Text Block] Changes in Warrants Stock Option Plans [Abstract] Schedule Of Stock Option Plans [Table Text Block] Stock option plans Tabular disclosure of various program within a company whereby employees are allowed to buy a specific number of stock options in the company for a specified amount of time. Amortization of Debt Discount (Premium) Amortization of Senior Term Debt Discount Basis Of Presentation [Abstract] Basis Of Presentation [Table] Sale of Stock [Axis] Sale of Stock [Axis] Disclosure Components Of Inventories [Abstract] Disclosure - Components of Inventories [Abstract] Inventory Disclosure [Table] Inventory Disclosure [Table] Inventory Disclosure [Line Items] Inventory Disclosure [Line Items] Inventory Disclosure [Line Items] Inventory Raw Materials and Purchased Parts Net Of Reserves Purchased Parts and Components Inventory Work In Process Net Of Reserves Work in Process Inventory Finished Goods Net Of Reserves Finished Goods Inventory Valuation Reserves Less: Reserve for Obsolescence Disclosure Long Term Debt Additional Information [Abstract] Disclosure - Long-Term Debt - Additional Information [Abstract] Line Of Credit Facility [Table] Longterm Debt Type [Axis] Longterm Debt Type [Domain] Range [Axis] Range [Domain] Debt Instrument [Axis] Debt Instrument, Name [Domain] Short-term Debt, Type [Axis] Disclosure Components Of Accrued Expenses [Abstract] Disclosure - Components of Accrued Expenses [Abstract] Accrued Liabilities [Table] Accrued Liabilities [Table] Accrued Liabilities [Line Items] Accrued Liabilities [Line Items] Accrued Liabilities [Line Items] Accrued Employee Benefits Current Accrued Wages and Related Costs Accrued Compensation Accrued Compensation Accrued Compensation as on balance sheet date Accrued Professional Fees Current Accrued Professional Services Product Warranty Accrual Classified Current Accrued Warranty Obligations Interest Payable, Current Accrued Interest Other Accrued Liabilities Current Other Accrued Expenses Disclosure Changes In Accrued Warranty Obligations [Abstract] Disclosure - Changes in Accrued Warranty Obligations [Abstract] Class Of Warrant Or Right [Table] Class Of Warrant Or Right [Line Items] Class Of Warrant Or Right [Line Items] Class of Warrant or Right [Line Items] Product Warranty Accrual Accrued Warranty Obligations at December 31, 2015 Accrued Warranty Obligations at September 30, 2016 Product Warranty Accrual Payments Reductions for Settling Warranties Product Warranty Accrual Warranties Issued Warranties Issued During Period Disclosure Components Of Long Term Debt [Abstract] Disclosure - Components of Long-Term Debt [Abstract] Schedule Of Long-Term Debt Instruments [Table] Notes Payable [Member] Notes Payable Notes Payable [Member] Notes Payable [Member] Group Three [Member] The principal is subject to a fixed semi-annual repayment schedule commencing October 31, 2013 over 48 months [Member] Group Three [Member] Group Eight [Member] The note carries a 0% interest, but imputed interest has been accrued based on a 12% discount rate and is reflected as a reduction in the principal [Member] The note carries a 0% interest rate, but imputed interest has been accrued based on a 12% discount rate and is reflected as a reduction in the principal Group Six [Member] The principal and interest is subject to a fixed blended repayment schedule of 36 months, commencing July 15, 2013 [Member] Group Six [Member] Debt Instrument [Line Items] Debt Instrument [Line Items] Debt Instrument [Line Items] Long-Term Debt Senior Secured debt Long term debt Total Net Long-Term Borrowings as of September 30, 2016 Group Two [Member] The principal and interest is subject to a fixed blended repayment schedule of 36 months, commencing July 15, 2013. Group Two [Member] Long Term Debt Maturities Repayment Terms Senior Secured debt repayment term Long term debt, fixed interest repayment term Debt Instrument Date Of First Required Payment 1 Long term debt repayment starting date Debt Instrument, Interest Rate, Stated Percentage Convertible, Senior Secured interest rate Interest percentage Long term debt, fixed interest rate Debt Instrument, Convertible, Conversion Price Fair Value Of Debt Embedded Conversion Price Adjustment Option Convertible debt issued with an embedded conversion price adjustment provision Fair value of debt embedded conversion price adjustment option Fair value of debt embedded conversion price adjustment option. Class Of Warrant Or Right Outstanding Number of Shares,Outstanding at December 31, 2015 Number of Shares,Outstanding at June 30, 2016 Derivative Liability For The Warrants To Purchase Outstanding Class Of Warrant Or Right Grants In Period Number of Shares,Issued During the Period Class of Warrant or Right, Grants in Period Class Of Warrant Or Right Exercised In Period Number of Shares,Exercised During the Period Class of Warrant or Right, Exercised in Period Class Of Warrant Or Right Expired In Period Number of Shares,Expired During the Period Class of Warrant or Right, Expired in Period Class Of Warrant Or Right Outstanding Weighted Average Remaining Contractual Terms Weighted average term of warrants Class of Warrant or Right Outstanding, Weighted Average Remaining Contractual Terms Schedule Of Share Based Compensation Shares Authorized Under Stock Option Plans By Exercise Price Range [Table] Option Indexed to Issuer's Equity, Type [Axis] Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding [Roll Forward] Number of shares outstanding Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding, Number Outstanding as of December 31, 2015 Outstanding, Beginning Balance Outstanding, Ending Balance Total Options Outstanding, Shares Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Granted Number of options granted Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period Exercised Cashless Option Exercise (in shares) Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period Expired or Forfeited Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Exercise Price [Abstract] Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Weighted Average Exercise Price [Abstract] Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Outstanding, Beginning Balance Outstanding, Ending Balance Total Options Outstanding, Weighted average exercise price EX-101.PRE 11 vuzi-20160930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 12 R1.htm IDEA: XBRL DOCUMENT

Document And Entity Information - shares	9 Months Ended
Document And Entity Information - shares	Sep. 30, 2016	Nov. 14, 2016
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2016
Document Fiscal Year Focus	2016
Document Fiscal Period Focus	Q3
Entity Registrant Name	Vuzix Corp
Entity Central Index Key	0001463972
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Trading Symbol	VUZI
Entity Common Stock, Shares Outstanding		17,560,686

XML 13 R2.htm IDEA: XBRL DOCUMENT

CONSOLIDATED BALANCE SHEETS - USD ($)	Sep. 30, 2016	Dec. 31, 2015
Current Assets
Cash and Cash Equivalents	$ 5,941,661	$ 11,877,058
Accounts Receivable	119,285	325,694
Inventories, Net	3,972,543	3,349,098
Manufacturing Vendor Prepayments	205,940	369,411
Prepaid Expenses and Other Assets	832,086	608,950
Total Current Assets	11,071,515	16,530,211
Fixed Assets, Net	3,070,452	2,015,433
Patents and Trademarks, Net	540,060	515,697
Software Development Costs, Net	286,450	501,288
Total Assets	14,968,477	19,562,629
Current Liabilities
Accounts Payable	1,529,554	907,434
Current Portion of Long-Term Debt, net of discount	1,333,709	55,790
Customer Deposits	43,383	27,847
Unearned Revenue	370,277	69,481
Accrued Expenses	1,053,288	734,497
Income and Other Taxes Payable	23,837	7,073
Total Current Liabilities	4,354,048	1,802,122
Long-Term Liabilities
Long-Term Derivative Liability	297,919	240,786
Long-Term Portion of Term Debt, net of discount	0	1,227,550
Long-Term Portion of Accrued Expenses	30,833	38,333
Long-Term Portion of Accrued Interest	0	160,967
Total Long-Term Liabilities	328,752	1,667,636
Total Liabilities	4,682,800	3,469,758
Stockholders' Equity
Preferred Stock	50	50
Common Stock	17,478	16,088
Additional Paid-in Capital	80,772,108	73,665,601
Accumulated Deficit	(70,503,959)	(57,588,868)
Total Stockholders' Equity	10,285,677	16,092,871
Total Liabilities and Stockholders' Equity	$ 14,968,477	$ 19,562,629

XML 14 R3.htm IDEA: XBRL DOCUMENT

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - 9 months ended Sep. 30, 2016 - USD ($)	Total	Preferred Stock	Common Stock	Additional Paid-in Capital	Accumulated Deficit
Balance at Dec. 31, 2015	$ 16,092,871	$ 50	$ 16,088	$ 73,665,601	$ (57,588,868)
Balance (in shares) at Dec. 31, 2015		49,626	16,087,951
Stock Based Compensation Expense	540,843			540,843
Public Offering	6,612,500		$ 1,150	6,611,350
Public Offering (in shares)			1,150,000
Public Offering Issuance Costs	(847,805)			(847,805)
Cashless Option Exercise	0		$ 1	(1)
Cashless Option Exercise (in shares)			632
Conversion of Note Payable & Accrued Interest	342,034		$ 152	341,882
Conversion of Note Payable & Accrued Interest (in shares)			152,016
Exercise of Warrants	45,000		$ 15	44,985
Exercise of Warrants (in shares)			15,000
Common Stock Awards	241,300		$ 40	241,260
Common Stock Awards (in Shares)			40,000
Stock Issues for Services	174,025		$ 32	173,993
Stock Issues for Services (in shares)			32,578
Net Loss for the Nine months ended September 30, 2016	(12,915,091)				(12,915,091)
Balance at Sep. 30, 2016	$ 10,285,677	$ 50	$ 17,478	$ 80,772,108	$ (70,503,959)
Balance (in shares) at Sep. 30, 2016		49,626	17,478,177

XML 15 R4.htm IDEA: XBRL DOCUMENT

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		9 Months Ended
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Sales of Products	$ 582,549	$ 890,629	$ 1,367,766	$ 2,014,015
Sales of Engineering Services	0	79,750	139,500	193,331
Total Sales	582,549	970,379	1,507,266	2,207,346
Cost of Sales - Products	819,116	612,346	2,069,964	1,590,284
Cost of Sales - Engineering Services	0	31,900	39,060	77,332
Total Cost of Sales	819,116	644,246	2,109,024	1,667,616
Gross Profit (Loss) (exclusive of depreciation shown separately below)	(236,567)	326,133	(601,758)	539,730
Operating Expenses:
Research and Development	2,177,957	944,426	5,121,713	2,191,624
Selling and Marketing	839,497	469,443	2,627,543	1,172,252
General and Administrative	1,274,698	1,120,982	3,350,441	5,079,131
Depreciation and Amortization	196,370	88,285	549,244	226,472
Loss from Operations	(4,725,089)	(2,297,003)	(12,250,699)	(8,129,749)
Other Income (Expense)
Interest Income	8,144	12,621	20,923	12,621
Other Taxes	(19,124)	(30,443)	(53,749)	(44,508)
Foreign Exchange (Loss) Gain	(13,781)	287	(21,267)	1,335
Gain (Loss) on Derivative Valuation	(59,120)	58,239	(57,133)	(968,467)
(Loss) on Fixed Asset Disposal	(25,890)	0	(25,890)	0
Amortization of Senior Term Debt Discount	(155,313)	(116,008)	(391,334)	(635,949)
Amortization of Deferred Financing Costs	(11,707)	(11,708)	(34,867)	(34,740)
Interest Expenses	(33,981)	(40,956)	(101,075)	(118,693)
Total Other Income (Expense)	(310,772)	(127,968)	(664,392)	(1,788,401)
Loss Before Income Taxes	(5,035,861)	(2,424,971)	(12,915,091)	(9,918,150)
Provision (Benefit) for Income Taxes	0	0	0	0
Net Loss	(5,035,861)	(2,424,971)	(12,915,091)	(9,918,150)
Preferred Stock Dividends	(410,153)	(386,377)	(1,203,693)	(1,121,860)
Loss Attributable to Common Stockholders	$ (5,446,014)	$ (2,811,348)	$ (14,118,784)	$ (11,040,010)
Basic and Diluted Loss per Share (Note 2)	$ (0.32)	$ (0.18)	$ (0.86)	$ (0.73)
Weighted-average Shares Outstanding Basic and Diluted	17,216,374	15,934,279	16,489,522	15,207,545

XML 16 R5.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Cash Flows from Operating Activities
Net Loss	$ (12,915,091)	$ (9,918,150)
Non-Cash Adjustments
Depreciation and Amortization	549,244	226,472
Amortization of Software Development Costs in Cost of Sales products	214,836	214,838
Loss on Disposal of Fixed Assets	25,890	0
Common Stock Awards Compensation Expense	241,300	1,669,700
Stock Based Option Compensation Expense	540,843	401,863
Amortization of Term Debt Discount and Debt Issuance Costs	426,201	670,689
Common Stock and Warrants Issued for Services	174,025	984,559
(Gain) Loss on Derivative Valuation	57,133	968,467
(Increase) Decrease in Operating Assets
Accounts Receivable	206,409	(281,034)
Inventories	(623,445)	(849,958)
Manufacturing Vendor Prepayments	163,471	(1,122,184)
Prepaid Expenses and Other Assets	(223,135)	(33,579)
Increase (Decrease) in Operating Liabilities
Accounts Payable	622,119	(1,785,638)
Accrued Expense	311,291	16,410
Customer Deposits	15,536	(100,016)
Unearned Revenue	300,796	20,628
Income and Other Taxes Payable	16,764	(25,630)
Accrued Interest & Long-Term Accrued Interest	(142,347)	67,858
Net Cash Flows Used in Operating Activities	(10,038,160)	(8,874,705)
Cash Flows from Investing Activities
Purchases of Fixed Assets	(1,551,141)	(553,448)
Investments in Patents and Trademarks	(103,375)	(166,305)
Net Cash Used in Investing Activities	(1,654,516)	(719,753)
Cash Flows from Financing Activities
Proceeds from Exercise of Warrants	45,000	1,262,626
Repayment of Capital Leases	0	(16,882)
Repayment of Long-Term Debt and Notes Payable	(52,416)	(150,362)
Proceeds from Public Offering	6,612,500	0
Issuance Costs of Public Offering	(847,805)	0
Proceeds from Preferred Stock Offering	0	24,813,000
Issuance Costs of Preferred Stock Offering	0	(214,169)
Net Change in Line of Credit	0	(112,500)
Net Cash Flows Provided by Financing Activities	5,757,279	25,581,713
Net (Decrease) Increase in Cash and Cash Equivalents	(5,935,397)	15,987,255
Cash and Cash Equivalents - Beginning of Period	11,877,058	84,967
Cash and Cash Equivalents - End of Period	5,941,661	16,072,222
Supplemental Disclosures
Interest Paid in Cash	7,860	21,690
Common Stock and Warrants Issued for Services	0	898,537
Conversion of Debt and Accrued Interest	342,034	427,500
Reclassification of Derivative Liability to Paid-In Capital upon Waiver of Certain Anti-Dilutive Provisions of Warrants and Convertible Debt	0	11,543,354
Reclassification of Derivative Liability Upon Warrant Exercises	$ 0	$ 2,855,463

XML 17 R6.htm IDEA: XBRL DOCUMENT

Basis of Presentation

9 Months Ended

Sep. 30, 2016

Organization, Consolidation and Presentation Of Financial Statements [Abstract]

Basis of Presentation

Note 1 — Basis of Presentation

The results of the Company’s operations for any interim period are not necessarily indicative of the results of the Company’s operations for any other interim period or for a full fiscal year.

For the nine months ended September 30, 2016 one customer accounted for approximately 14% of sales. There was no single customer in the 2015 period that accounted for over 10% of total sales.

XML 18 R7.htm IDEA: XBRL DOCUMENT

Loss Per Share

9 Months Ended

Sep. 30, 2016

Earnings Per Share [Abstract]

Loss Per Share

Note 2 – Loss Per Share

XML 19 R8.htm IDEA: XBRL DOCUMENT

Inventories, Net

9 Months Ended

Sep. 30, 2016

Inventory Disclosure [Abstract]

Inventories,Net

Note 3 — Inventories, Net

Inventories are stated at the lower of cost (determined on the first-in, first-out or specific identification method) or market and consisted of the following:

	September 30, 2016		December 31, 2015

Purchased Parts and Components	$	3,260,075	$	3,069,261
Work in Process		356,407		154,880
Finished Goods		973,348		612,451
Less: Reserve for Obsolescence		(617,287)		(487,494)
Net	$	3,972,543	$	3,349,098

XML 20 R9.htm IDEA: XBRL DOCUMENT

Accrued Expenses

9 Months Ended

Sep. 30, 2016

Payables and Accruals [Abstract]

Accrued Expenses

Note 4 — Accrued Expenses

Accrued expenses consisted of the following:

	September 30, 2016		December 31, 2015

Accrued Wages and Related Costs	$	90,316	$	102,792
Accrued Compensation		358,719		358,719
Accrued Professional Services		193,196		89,000
Accrued Warranty Obligations		55,511		64,002
Accrued Interest		345,546		109,984
Other Accrued Expenses		10,000		10,000

Total	$	1,053,288	$	734,497

Accrued Warranty Obligations at December 31, 2015	$	64,002
Reductions for Settling Warranties		(58,320)
Warranties Issued During Period		49,829

Accrued Warranty Obligations at September 30, 2016	$	55,511

XML 21 R10.htm IDEA: XBRL DOCUMENT

Derivative Liability and Fair Value Measurements

9 Months Ended

Sep. 30, 2016

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Liability and Fair Value Measurements

Note 5 – Derivative Liability and Fair Value Measurements

- Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;

We measure certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis are as follows at September 30, 2016:

	Total		Level 1		Level 2		Level 3

Warrant Liability	$	297,919	$	—	$	—	$	297,919
Total liabilities measured at fair value (Long-Term)	$	297,919	$	—	$	—	$	297,919

We measure certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis are as follows at December 31, 2015:

	Total		Level 1		Level 2		Level 3
Warrant Liability	$	240,786	$	—	$	—	$	240,786
Total liabilities measured at fair value (Long-Term)	$	240,786	$	—	$	—	$	240,786

Fair value – December 31, 2015	$	240,786

Change in fair value for the period of warrant derivative liability		57,133

Fair value – September 30, 2016	$	297,919

The Monte Carlo Options Lattice pricing model was used to estimate the fair value of the warrants outstanding:

	September 30,			December 31,
	2016			2015
Assumptions for Pricing Model:
Expected term in years		1.85			2.60
Volatility		116	%		103	%
Risk-free interest rate		0.88	%		1.06	%
Expected annual dividends		None			None

Fluctuations in the variables used in calculating the value of the Company’s derivative liability could have a significant impact on the resulting valuation.

- Definition

The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6441202&loc=d3e80720-113993

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4C
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5624171-113959

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=64837297&loc=d3e41620-113959

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4B
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5624163-113959

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5579240-113959

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4D
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5624177-113959

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=35736893&loc=d3e80784-113994

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=64837297&loc=d3e41641-113959

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5579245-113959

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4H
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5624258-113959

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=35736893&loc=d3e80748-113994

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5708775-113959

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5708773-113959

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4A
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5618551-113959

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1B
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5580258-113959

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4E
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5624181-113959

Reference 17: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 25
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6886632&loc=d3e76258-113986

Reference 18: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=64837297&loc=d3e41638-113959

Reference 19: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(n))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

+ Details

XML 22 R11.htm IDEA: XBRL DOCUMENT

Long-Term Debt

9 Months Ended

Sep. 30, 2016

Debt Disclosure [Abstract]

Long-Term Debt

Note 6 — Long-Term Debt

Long-term debt consisted of the following:

	September 30,		December 31,
	2016		2015

Note payable for research and development equipment. The principal is subject to a fixed semi-annual repayment schedule commencing October 31, 2013 over 48 months. The note carries a 0% interest rate.	$	24,459	$	59,917
The note carries a 0% interest rate, but imputed interest has been accrued based on a 12% discount rate and is reflected as a reduction in the principal.		(2,109)		(21,085)
Note payable for which the principal and interest is subject to a fixed blended repayment schedule of 36 months, commencing July 15, 2013. The loan bears interest at 12% per year and is secured by a subordinated position in all the assets of the Company.		—		16,958
Convertible, Senior Secured Notes payable. The principal is due June 3, 2017 and no principal payments are required prior to maturity. The notes carry a 5% interest rate, payable upon the notes’ maturities. Both the principal plus accrued interest is convertible into shares of the Company’s common stock at $2.25 per share, subject to normal adjustments. The notes are secured by a first security position in all the assets of the Company.		1,591,739		1,915,155
Convertible, Senior Secured Notes Payable Issuance Costs of $139,340, net of accumulated amortization. The estimated aggregate amortization expense is approximately $11,000 for the remainder of fiscal 2016 and approximately $20,000 in the following fiscal year.		(31,207)		(66,074)
Unamortized debt discount related to derivative liability associated with above notes’ conversion price that was subject to adjustment in the event of subsequent equity sales at a lower purchase price (subject to certain exceptions). Upon issuance on June 3, 2014 the discount was $1,938,988.		(249,173)		(621,531)

		1,333,709		1,283,340
Less: Amount Due Within One Year		(1,333,709)		(55,790)

Amount Due After One Year	$	—	$	1,227,550

The calendar year aggregate maturities for all long-term debt exclusive of discounts as of September 30, 2016 are as follows:

Total Aggregate Maturity For Period	Amounts

2016	$	24,459
2017		1,591,739
Total Required Principal Payments Exclusive of Debt Discounts		1,616,198
Total Unamortized Debt Discounts and Deferred Costs		(282,489)

Total Net Long-Term Borrowings as of September 30, 2016	$	1,333,709

XML 23 R12.htm IDEA: XBRL DOCUMENT

Income Taxes

9 Months Ended

Sep. 30, 2016

Income Tax Disclosure [Abstract]

Income Taxes

Note 7 — Income Taxes

XML 24 R13.htm IDEA: XBRL DOCUMENT

Capital Stock

9 Months Ended

Sep. 30, 2016

Stockholders' Equity Note [Abstract]

Capital Stock

Note 8 — Capital Stock

Preferred stock

Common Stock

- Definition

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB Topic 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74567-122707

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(e))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB Topic 4.C)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(d))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Preferred Stock
-URI http://asc.fasb.org/extlink&oid=6521494

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644

+ Details

XML 25 R14.htm IDEA: XBRL DOCUMENT

Stock Warrants

9 Months Ended

Sep. 30, 2016

Stockholders' Equity Note [Abstract]

Stock Warrants

Note 9 — Stock Warrants

A summary of the various changes in warrants during the nine-month period ended September 30, 2016 is as follows:

			Weighted
			Average
	Number of		Exercise
	Shares		Price

Outstanding at December 31, 2015		535,091	$	2.43
Issued During the Period		—		—
Exercised During the Period		(15,000)		3.00
Expired During the Period		—		—

Outstanding at September 30, 2016		520,091	$	2.37

The outstanding warrants as of September 30, 2016 expire from November 3, 2017 to August 5, 2018. The weighted average remaining term of the warrants is 1.5 years.

XML 26 R15.htm IDEA: XBRL DOCUMENT

Stock Option Plans

9 Months Ended

Sep. 30, 2016

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Stock Option Plans

Note 10 — Stock Option Plans

A summary of stock option activity for the nine months ended September 30, 2016 is as follows:

			Weighted
			Average
	Number of		Exercise
	Shares		Price

Outstanding at December 31, 2015		1,022,789	$	4.59
Granted		60,750		6.27
Exercised		(1,000)		2.60
Expired or Forfeited		(31,523)		5.58

Outstanding at September 30, 2016		1,051,016	$	4.65

The weighted average remaining contractual term for all options as of September 30, 2016 and December 31, 2015 was 7.0 years and 7.6 years respectively.

No options were exercised for cash during the nine months ended September 30, 2016 and 2015. There were 1,000 options exercised on a cashless basis during the three months ended September 30, 2016.

The following summary table shows the assumptions used to the fair value of options granted during the nine-month period ended September 30, 2016 and their estimated value:

• Expected term in years	7.9 years
• Volatility	107.2 - 109.7		%
• Risk-free interest rate		1.28 - 1.68	%
• Expected annual dividends		None
• Fair value of options issued	$	333,434

- Definition

The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.

+ References + Details

XML 27 R16.htm IDEA: XBRL DOCUMENT

Litigation

9 Months Ended

Sep. 30, 2016

Litigation Disclosure [Abstract]

Litigation

Note 11 — Litigation

We are not currently involved in any current or pending legal proceeding or litigation.

XML 28 R17.htm IDEA: XBRL DOCUMENT

Contractual Obligations

9 Months Ended

Sep. 30, 2016

Contractual Obligations [Abstract]

Contractual Obligations

Note 12 — Contractual Obligations

Future minimum payments required under operating lease obligations as of September 30, 2016 are as follows:

	Total
	Minimum
	Lease
	Payments
2016 (3 months remaining)	$	92,849
2017		346,039
2018		335,248
2019		335,248
2020		279,373
Total	$	1,388,757

Under the lease agreements described above, the Company is required to pay the pro rata share of the real property taxes and assessments, expenses and other charges associated with these facilities.

Rent expense for the nine months ended September 30, 2016 and 2015 totaled $371,239 and $65,065, respectively.

XML 29 R18.htm IDEA: XBRL DOCUMENT

Recent Accounting Pronouncements

9 Months Ended

Sep. 30, 2016

Accounting Changes and Error Corrections [Abstract]

Recent Accounting Pronouncements

Note 13 — Recent Accounting Pronouncements

There are no other recent accounting pronouncements that are expected to have a material impact on the condensed consolidated financial statements.

- Definition

The entire disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Change in Accounting Principle
-URI http://asc.fasb.org/extlink&oid=6507316

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Direct Effects of a Change in Accounting Principle
-URI http://asc.fasb.org/extlink&oid=66092750

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=64853466&loc=d3e22583-107794

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Indirect Effects of a Change in Accounting Principle
-URI http://asc.fasb.org/extlink&oid=6515603

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=64853466&loc=d3e22580-107794

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 270
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.10-01.(b)(6))
-URI http://asc.fasb.org/extlink&oid=27015980&loc=d3e46468-122699

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Accounting Change
-URI http://asc.fasb.org/extlink&oid=6503790

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=64853466&loc=d3e22499-107794

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Retrospective Application
-URI http://asc.fasb.org/extlink&oid=6523989

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 270
-SubTopic 10
-Section 45
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=68064558&loc=d3e765-108305

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 270
-SubTopic 10
-Section 45
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=68064558&loc=d3e725-108305

+ Details

XML 30 R19.htm IDEA: XBRL DOCUMENT

Inventories, Net (Tables)

9 Months Ended

Sep. 30, 2016

Inventory Disclosure [Abstract]

Schedule of Inventories

Inventories are stated at the lower of cost (determined on the first-in, first-out or specific identification method) or market and consisted of the following:

	September 30, 2016		December 31, 2015

Purchased Parts and Components	$	3,260,075	$	3,069,261
Work in Process		356,407		154,880
Finished Goods		973,348		612,451
Less: Reserve for Obsolescence		(617,287)		(487,494)
Net	$	3,972,543	$	3,349,098

XML 31 R20.htm IDEA: XBRL DOCUMENT

Accrued Expenses (Tables)

9 Months Ended

Sep. 30, 2016

Payables and Accruals [Abstract]

Components of Accrued Expenses

Accrued expenses consisted of the following:

	September 30, 2016		December 31, 2015

Accrued Wages and Related Costs	$	90,316	$	102,792
Accrued Compensation		358,719		358,719
Accrued Professional Services		193,196		89,000
Accrued Warranty Obligations		55,511		64,002
Accrued Interest		345,546		109,984
Other Accrued Expenses		10,000		10,000

Total	$	1,053,288	$	734,497

Changes in Accrued Warranty Obligations

The changes in the Company’s accrued warranty obligations for the nine months ended September 30, 2016 were as follows:

Accrued Warranty Obligations at December 31, 2015	$	64,002
Reductions for Settling Warranties		(58,320)
Warranties Issued During Period		49,829

Accrued Warranty Obligations at September 30, 2016	$	55,511

XML 32 R21.htm IDEA: XBRL DOCUMENT

Derivative Liability and Fair Value Measurements (Tables)

9 Months Ended

Sep. 30, 2016

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule Of Assets And Liabilities Measured At Fair Value On A Recurring Basis

Assets and liabilities measured at fair value on a recurring basis are as follows at September 30, 2016:

	Total		Level 1		Level 2		Level 3

Warrant Liability	$	297,919	$	—	$	—	$	297,919
Total liabilities measured at fair value (Long-Term)	$	297,919	$	—	$	—	$	297,919

We measure certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis are as follows at December 31, 2015:

	Total		Level 1		Level 2		Level 3
Warrant Liability	$	240,786	$	—	$	—	$	240,786
Total liabilities measured at fair value (Long-Term)	$	240,786	$	—	$	—	$	240,786

Schedule of Fair Value Level 3 warrant liabilities

Fair value – December 31, 2015	$	240,786

Change in fair value for the period of warrant derivative liability		57,133

Fair value – September 30, 2016	$	297,919

Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques

The Monte Carlo Options Lattice pricing model was used to estimate the fair value of the warrants outstanding:

	September 30,			December 31,
	2016			2015
Assumptions for Pricing Model:
Expected term in years		1.85			2.60
Volatility		116	%		103	%
Risk-free interest rate		0.88	%		1.06	%
Expected annual dividends		None			None

XML 33 R22.htm IDEA: XBRL DOCUMENT

Long-Term Debt (Tables)

9 Months Ended

Sep. 30, 2016

Debt Disclosure [Abstract]

Components of Long-Term Debt

Long-term debt consisted of the following:

	September 30,		December 31,
	2016		2015

Note payable for research and development equipment. The principal is subject to a fixed semi-annual repayment schedule commencing October 31, 2013 over 48 months. The note carries a 0% interest rate.	$	24,459	$	59,917
The note carries a 0% interest rate, but imputed interest has been accrued based on a 12% discount rate and is reflected as a reduction in the principal.		(2,109)		(21,085)
Note payable for which the principal and interest is subject to a fixed blended repayment schedule of 36 months, commencing July 15, 2013. The loan bears interest at 12% per year and is secured by a subordinated position in all the assets of the Company.		—		16,958
Convertible, Senior Secured Notes payable. The principal is due June 3, 2017 and no principal payments are required prior to maturity. The notes carry a 5% interest rate, payable upon the notes’ maturities. Both the principal plus accrued interest is convertible into shares of the Company’s common stock at $2.25 per share, subject to normal adjustments. The notes are secured by a first security position in all the assets of the Company.		1,591,739		1,915,155
Convertible, Senior Secured Notes Payable Issuance Costs of $139,340, net of accumulated amortization. The estimated aggregate amortization expense is approximately $11,000 for the remainder of fiscal 2016 and approximately $20,000 in the following fiscal year.		(31,207)		(66,074)
Unamortized debt discount related to derivative liability associated with above notes’ conversion price that was subject to adjustment in the event of subsequent equity sales at a lower purchase price (subject to certain exceptions). Upon issuance on June 3, 2014 the discount was $1,938,988.		(249,173)		(621,531)

		1,333,709		1,283,340
Less: Amount Due Within One Year		(1,333,709)		(55,790)

Amount Due After One Year	$	—	$	1,227,550

Aggregate maturities for all long-term borrowings

The calendar year aggregate maturities for all long-term debt exclusive of discounts as of September 30, 2016 are as follows:

Total Aggregate Maturity For Period	Amounts

2016	$	24,459
2017		1,591,739
Total Required Principal Payments Exclusive of Debt Discounts		1,616,198
Total Unamortized Debt Discounts and Deferred Costs		(282,489)

Total Net Long-Term Borrowings as of September 30, 2016	$	1,333,709

- Definition

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6479336&loc=d3e64711-112823

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(e),(f))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=64930739&loc=d3e28878-108400

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21538-112644

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=64930785&loc=d3e28541-108399

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=64930785&loc=d3e28551-108399

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21521-112644

+ Details

XML 34 R23.htm IDEA: XBRL DOCUMENT

Stock Warrants (Tables)

9 Months Ended

Sep. 30, 2016

Stockholders' Equity Note [Abstract]

Changes in Warrants

A summary of the various changes in warrants during the nine-month period ended September 30, 2016 is as follows:

			Weighted
			Average
	Number of		Exercise
	Shares		Price

Outstanding at December 31, 2015		535,091	$	2.43
Issued During the Period		—		—
Exercised During the Period		(15,000)		3.00
Expired During the Period		—		—

Outstanding at September 30, 2016		520,091	$	2.37

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References + Details

XML 35 R24.htm IDEA: XBRL DOCUMENT

Stock Option Plans (Tables)

9 Months Ended

Sep. 30, 2016

Stock Option Plans [Abstract]

Stock option plans

summary of stock option activity for the nine months ended September 30, 2016 is as follows:

			Weighted
			Average
	Number of		Exercise
	Shares		Price

Outstanding at December 31, 2015		1,022,789	$	4.59
Granted		60,750		6.27
Exercised		(1,000)		2.60
Expired or Forfeited		(31,523)		5.58

Outstanding at September 30, 2016		1,051,016	$	4.65

Share-based Payment Award, Stock Options, Valuation Assumptions

The following summary table shows the assumptions used to the fair value of options granted during the nine-month period ended September 30, 2016 and their estimated value:

• Expected term in years	7.9 years
• Volatility	107.2 - 109.7		%
• Risk-free interest rate		1.28 - 1.68	%
• Expected annual dividends		None
• Fair value of options issued	$	333,434

XML 36 R25.htm IDEA: XBRL DOCUMENT

Contractual Obligations (Tables)

9 Months Ended

Sep. 30, 2016

Contractual Obligation [Abstract]

Contractual Payment Obligations for Operating Leases

Future minimum payments required under operating lease obligations as of September 30, 2016 are as follows:

	Total
	Minimum
	Lease
	Payments
2016 (3 months remaining)	$	92,849
2017		346,039
2018		335,248
2019		335,248
2020		279,373
Total	$	1,388,757

XML 37 R26.htm IDEA: XBRL DOCUMENT

Basis of Presentation (Additional Information) (Detail) - USD ($)		3 Months Ended		9 Months Ended		12 Months Ended
	Jul. 11, 2016	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015	Dec. 31, 2015	Dec. 31, 2014
Basis Of Presentation [Line Items]
Retained Earnings Accumulated Deficit		$ (70,503,959)		$ (70,503,959)		$ (57,588,868)
Net Income (Loss) Attributable To Parent		$ (5,035,861)	$ (2,424,971)	(12,915,091)	$ (9,918,150)	$ 13,427,478	$ 7,868,858
Stock Issued During Period, Shares, New Issues	1,150,000
Shares Issued, Price Per Share	$ 5.75
Stock Issued During Period, Value, New Issues	$ 6,612,500			$ 6,612,500
Proceeds from Issuance Initial Public Offering	$ 5,764,695
Customer One [Member] \| Sales Revenue, Goods, Net [Member]
Basis Of Presentation [Line Items]
Concentration Risk, Percentage				14.00%

XML 38 R27.htm IDEA: XBRL DOCUMENT

Loss Per Share (Additional Information) (Detail)	9 Months Ended	12 Months Ended
Loss Per Share (Additional Information) (Detail)	Sep. 30, 2016	Dec. 31, 2015
Earnings Per Share, Potentially Dilutive Securities	7,241,147	7,366,036

XML 39 R28.htm IDEA: XBRL DOCUMENT

Inventories, Net (Components of Inventories) (Detail) - USD ($)	Sep. 30, 2016	Dec. 31, 2015
Inventory Disclosure [Line Items]
Purchased Parts and Components	$ 3,260,075	$ 3,069,261
Work in Process	356,407	154,880
Finished Goods	973,348	612,451
Less: Reserve for Obsolescence	(617,287)	(487,494)
Net	$ 3,972,543	$ 3,349,098

XML 40 R29.htm IDEA: XBRL DOCUMENT

Accrued Expenses (Components of Accrued Expenses) (Detail) - USD ($)	Sep. 30, 2016	Dec. 31, 2015
Accrued Liabilities [Line Items]
Accrued Wages and Related Costs	$ 90,316	$ 102,792
Accrued Compensation	358,719	358,719
Accrued Professional Services	193,196	89,000
Accrued Warranty Obligations	55,511	64,002
Accrued Interest	345,546	109,984
Other Accrued Expenses	10,000	10,000
Total	$ 1,053,288	$ 734,497

XML 41 R30.htm IDEA: XBRL DOCUMENT

Accrued Expenses (Changes in Accrued Warranty Obligations) (Detail)	9 Months Ended
	Sep. 30, 2016 USD ($)
Class Of Warrant Or Right [Line Items]
Accrued Warranty Obligations at December 31, 2015	$ 64,002
Reductions for Settling Warranties	(58,320)
Warranties Issued During Period	49,829
Accrued Warranty Obligations at September 30, 2016	$ 55,511

XML 42 R31.htm IDEA: XBRL DOCUMENT

Accrued Expenses - Additional Information (Detail) - USD ($)	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Dec. 31, 2015
Officers Compensation Payable Compounding Monthly Interest Rate	8.00%
Accrued Employee Benefits	$ 358,719		$ 358,719
Interest Expense, Other	28,492	$ 29,340
Interest Payable	$ 131,687		$ 97,801

XML 43 R32.htm IDEA: XBRL DOCUMENT

Derivative Liability and Fair Value Measurements (Schedule of Assets And Liabilities Measured At Fair Value On A Recurring Basis) (Detail) - USD ($)	Sep. 30, 2016	Dec. 31, 2015
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant Liability	$ 297,919	$ 240,786
Total liabilities measured at fair value (Long-Term)	297,919	240,786
Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant Liability	0	0
Total liabilities measured at fair value (Long-Term)	0	0
Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant Liability	0	0
Total liabilities measured at fair value (Long-Term)	0	0
Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant Liability	297,919	240,786
Total liabilities measured at fair value (Long-Term)	$ 297,919	$ 240,786

XML 44 R33.htm IDEA: XBRL DOCUMENT

Derivative Liability and Fair Value Measurements (Schedule of Fair Value Level 3 Warrant Liabilities) (Detail)	9 Months Ended
	Sep. 30, 2016 USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value - December 31, 2015	$ 240,786
Warrant Liabilities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Change in fair value for the period of warrant derivative liability	57,133
Fair value - September 30, 2016	$ 297,919

XML 45 R34.htm IDEA: XBRL DOCUMENT

Derivative Liability and Fair Value Measurements (Estimate the fair value of warrants outstanding) (Detail)	9 Months Ended	12 Months Ended
	Sep. 30, 2016	Dec. 31, 2015
Assumptions for Pricing Model:
Expected annual dividends	0.00%	0.00%
Monte Carlo Options Lattice Pricing Model Warrants Outstanding
Assumptions for Pricing Model:
Expected term in years	1 year 10 months 6 days	2 years 7 months 6 days
Volatility	116.00%	103.00%
Risk-free interest rate	0.88%	1.06%

XML 46 R35.htm IDEA: XBRL DOCUMENT

Derivative Liability and Fair Value Measurements (Additional Information) (Detail) - USD ($)		9 Months Ended
	Jun. 03, 2014	Sep. 30, 2016	Dec. 31, 2015	Dec. 31, 2014
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right		45,100	45,100
Convertible Debt				$ 3,000,000
Fair Value Of Debt Embedded Conversion Price Adjustment Option	$ 1,938,988
Percentage of Outstanding Warrants Issued By Parent		86.00%

XML 47 R36.htm IDEA: XBRL DOCUMENT

Long-Term Debt (Components of Long-Term Debt) (Detail) - USD ($)	Sep. 30, 2016	Dec. 31, 2015
Debt Instrument [Line Items]
Long term debt	$ 1,333,709	$ 1,283,340
Less: Amount Due Within One Year	(1,333,709)	(55,790)
Amount Due After One Year	0	1,227,550
The note carries a 0% interest, but imputed interest has been accrued based on a 12% discount rate and is reflected as a reduction in the principal [Member]
Debt Instrument [Line Items]
Long term debt	(2,109)	(21,085)
Convertible to shares of the Company's common stock at 2.25, subject to adjustment [Member]
Debt Instrument [Line Items]
Long term debt	1,591,739	1,915,155
Unamortized debt discount related to derivative liability associated with above notes’ conversion price that was subject to adjustment in the event of subsequent equity sales at a lower purchase price (subject to certain exceptions). Upon issuance on June 3, 2014 the discount was $1,938,988 which is being amortized as interest expense over the life of the loan or sooner if the related debt is converted [Member]
Debt Instrument [Line Items]
Unamortized Debt Discount Related To Derivative Liability	(249,173)	(621,531)
Convertible, Senior Secured Notes Issued Debt Issuance Costs [Member]
Debt Instrument [Line Items]
Long term debt	(31,207)	(66,074)
Notes Payable [Member] \| The principal is subject to a fixed semi-annual repayment schedule commencing October 31, 2013 over 48 months [Member]
Debt Instrument [Line Items]
Long term debt	24,459	59,917
Notes Payable [Member] \| The principal and interest is subject to a fixed blended repayment schedule of 36 months, commencing July 15, 2013 [Member]
Debt Instrument [Line Items]
Long term debt	$ 0	$ 16,958

XML 48 R37.htm IDEA: XBRL DOCUMENT

Long-Term Debt (Components of Long-Term Debt) (Parenthetical) (Detail) - USD ($)		9 Months Ended	12 Months Ended
	Jun. 03, 2014	Sep. 30, 2016	Dec. 31, 2015
Debt Instrument [Line Items]
Fair Value Of Debt Embedded Conversion Price Adjustment Option	$ 1,938,988
Long-term Debt, Maturities, Repayments of Principal in Next Twelve Months		$ 1,591,739
The principal and interest is subject to a fixed blended repayment schedule of 36 months, commencing July 15, 2013.
Debt Instrument [Line Items]
Long term debt, fixed interest repayment term		36 months	36 months
Long term debt repayment starting date		Jul. 15, 2013	Jul. 15, 2013
Long term debt, fixed interest rate		12.00%	12.00%
The principal is subject to a fixed semi-annual repayment schedule commencing October 31, 2013 over 48 months [Member]
Debt Instrument [Line Items]
Long term debt, fixed interest repayment term		48 months	48 months
Long term debt repayment starting date		Oct. 31, 2013	Oct. 31, 2013
Long term debt, fixed interest rate		0.00%	0.00%
Unamortized debt discount related to derivative liability associated with above notes’ conversion price that was subject to adjustment in the event of subsequent equity sales at a lower purchase price (subject to certain exceptions). Upon issuance on June 3, 2014 the discount was $1,938,988 [Member]
Debt Instrument [Line Items]
Fair Value Of Debt Embedded Conversion Price Adjustment Option		$ 1,938,988	$ 1,938,988
Convertible, Senior Secured Notes Issued Debt Issuance Costs [Member]
Debt Instrument [Line Items]
Long-term Debt, Maturities, Repayments of Principal in Next Twelve Months		$ 11,000	$ 20,000
Debt Issuance Costs, Net	$ 139,340
Convertible Senior Secured Notes payable [Member]
Debt Instrument [Line Items]
Long term debt repayment starting date		Jun. 03, 2017	Jun. 03, 2017
Long term debt, fixed interest rate		5.00%	5.00%
Debt Instrument, Convertible, Conversion Price		$ 2.25	$ 2.25

XML 49 R38.htm IDEA: XBRL DOCUMENT

Long-Term Debt (Aggregate Maturities For All Long Term Borrowings) (Detail) - USD ($)	Sep. 30, 2016	Dec. 31, 2015
Debt Instrument [Line Items]
2016	$ 24,459
2017	1,591,739
Total Required Principal Payments Exclusive of Debt Discounts	1,616,198
Total Unamortized Debt Discounts and Deferred Costs	(282,489)
Total Net Long-Term Borrowings as of September 30, 2016	$ 1,333,709	$ 1,283,340

XML 50 R39.htm IDEA: XBRL DOCUMENT

Long-Term Debt (Additional Information) (Detail) - USD ($)	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Line of Credit Facility [Line Items]
Amortization of Financing Costs and Discounts	$ 426,201	$ 670,689
Senior Secured Convertible Note [Member]
Line of Credit Facility [Line Items]
Debt Conversion, Original Debt, Amount	$ 323,415
Debt Conversion, Converted Instrument, Shares Issued	143,740
Accrued Interest Value Converted into Stock	$ 18,620
Accrued Interest Converted into Common Stock	8,276
Amortization of Financing Costs and Discounts	$ 47,811

XML 51 R40.htm IDEA: XBRL DOCUMENT

Capital Stock (Additional Information) (Detail) - USD ($)			9 Months Ended
	Jul. 11, 2016	Jan. 02, 2015	Sep. 30, 2016	Dec. 31, 2015
Preferred Stock, Shares Authorized			5,000,000
Public Offering (in shares)	1,150,000
Shares Issued, Price Per Share	$ 5.75
Public Offering	$ 6,612,500		$ 6,612,500
Dividends Payable			$ 2,717,773	$ 1,514,081
Common Stock, Shares Authorized			100,000,000
Common Stock, Shares, Issued			17,478,177
Common Stock, Shares, Outstanding				16,087,951
Common Stock, Par or Stated Value Per Share			$ 0.001
Proceeds from Issuance Initial Public Offering	$ 5,764,695
Series A Preferred Stock [Member]
Conversion of Stock, Description			Each share of Series A Preferred Stock is convertible, at the option of the Series A holder, into 100 shares of the Companys common stock (determined by dividing the Series A Original Issue Price of $500 by the Series A Conversion Price. The Series A Conversion Price is $5.00, subject to adjustment in the event of stock splits, dividends or other combinations
Preferred Stock, Dividend Rate, Percentage			6.00%
Preferred Stock, Shares Outstanding			49,626
Preferred Stock, Shares Issued			49,626
Series A Preferred Stock [Member] \| Corporation [Member]
Public Offering (in shares)		49,626
Shares Issued, Price Per Share		$ 500
Public Offering		$ 24,813,000

XML 52 R41.htm IDEA: XBRL DOCUMENT

Stock Warrants (Changes in Warrants) (Detail) - $ / shares	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Class Of Warrant Or Right [Line Items]
Number of Shares,Outstanding at December 31, 2015	535,091
Number of Shares,Issued During the Period	0
Number of Shares,Exercised During the Period	(15,000)	(553,250)
Number of Shares,Expired During the Period	0
Number of Shares,Outstanding at June 30, 2016	520,091
Weighted Average Exercise Price,Outstanding at December 31, 2015	$ 2.43
Weighted Average Exercise Price,Issued During the period	0
Weighted Average Exercise Price,Excercised During the period	3.00
Weighted Average Exercise Price,Expired During the period	0
Weighted Average Exercise Price Outstanding at September 30, 2016	$ 2.37

XML 53 R42.htm IDEA: XBRL DOCUMENT

Stock Warrants (Additional Information) (Detail) - USD ($)	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Class of Warrant or Right [Line Items]
Weighted average term of warrants	1 year 6 months
Class Of Warrant Or Right Exercised In Period	15,000	553,250
Proceeds from Warrant Exercises	$ 45,000	$ 1,262,626

XML 54 R43.htm IDEA: XBRL DOCUMENT

Stock Option Plans (Summary of Stock Option Activity) (Detail) - $ / shares	3 Months Ended	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2016
Number of shares outstanding
Exercised	(1,000)
Employee Stock Option [Member]
Number of shares outstanding
Outstanding, Beginning Balance		1,022,789
Granted		60,750
Exercised		(1,000)
Expired or Forfeited		(31,523)
Outstanding, Ending Balance	1,051,016	1,051,016
Weighted Average Exercise Price
Outstanding, Beginning Balance		$ 4.59
Granted		6.27
Exercised		2.60
Expired or Forfeited		5.58
Outstanding, Ending Balance	$ 4.65	$ 4.65

XML 55 R44.htm IDEA: XBRL DOCUMENT

Stock Option Plans (Assumptions Used To Compute The Fair Value Of Stock Options) (Detail)	9 Months Ended
	Sep. 30, 2016 USD ($)
Assumptions Used To Compute Fair Value Of Stock Options [Line Items]
Expected term in years	7 years 10 months 24 days
Expected annual dividends	$ 0
Fair value of options issued	$ 333,434
Minimum [Member]
Assumptions Used To Compute Fair Value Of Stock Options [Line Items]
Volatility	107.20%
Risk-free interest rate	1.28%
Maximum [Member]
Assumptions Used To Compute Fair Value Of Stock Options [Line Items]
Volatility	109.70%
Risk-free interest rate	1.68%

XML 56 R45.htm IDEA: XBRL DOCUMENT

Stock Option Plans (Additional Information) (Detail) - USD ($)	3 Months Ended	9 Months Ended	12 Months Ended
	Sep. 30, 2016	Sep. 30, 2016	Dec. 31, 2015
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Exercisable Options Outstanding Shares	569,692	569,692
Weighted average exercise price per share	$ 4.93	$ 4.93
Unvested Options Outstanding, Shares	482,324	482,324
Unvested Options Outstanding, Weighted average exercise price		$ 4.34
Unvested Options Outstanding Weighted average remaining life (yrs)		7 years
Weighted average remaining contractual term on unvested options		7 years 1 month 6 days
Unrecognized stock compensation expense	$ 2,000,000	$ 2,000,000
Weighted average recognition period		1 year 7 months 6 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term		7 years	7 years 7 months 6 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value		$ 4,791,846
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period	1,000

XML 57 R46.htm IDEA: XBRL DOCUMENT

Contractual Obligations (Future Minimum Payments Required Under Operating Lease) (Detail)	Sep. 30, 2016 USD ($)
Future Minimum Payments Required Under Operating Lease [Line Items]
2016 (3 months remaining)	$ 92,849
2017	346,039
2018	335,248
2019	335,248
2020	279,373
Total	$ 1,388,757

XML 58 R47.htm IDEA: XBRL DOCUMENT

Contractual Obligations (Additional Information) (Detail) - USD ($)	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Commitment Contingencies Disclosure [Line Items]
Lease Expiration Date	Oct. 03, 2020
Operating Leases, Rent Expense	$ 371,239	$ 65,065
Operating Lease Commencement Date	Oct. 03, 2015

EXCEL 59 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 63 FilingSummary.xml IDEA: XBRL DOCUMENT 3.5.0.2 html 73 242 1 false 27 0 false 4 false false R1.htm 101 - Document - Document And Entity Information Sheet http://www.vuzix.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 102 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://www.vuzix.com/role/ConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 103 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY Sheet http://www.vuzix.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY Statements 3 false false R4.htm 104 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://www.vuzix.com/role/ConsolidatedStatementsOfOperations CONSOLIDATED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 105 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.vuzix.com/role/CondensedConsolidatedStatementsOfCashFlows CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 5 false false R6.htm 106 - Disclosure - Basis of Presentation Sheet http://www.vuzix.com/role/BasisOfPresentation Basis of Presentation Notes 6 false false R7.htm 107 - Disclosure - Loss Per Share Sheet http://www.vuzix.com/role/LossPerShare Loss Per Share Notes 7 false false R8.htm 108 - Disclosure - Inventories, Net Sheet http://www.vuzix.com/role/InventoriesNet Inventories, Net Notes 8 false false R9.htm 109 - Disclosure - Accrued Expenses Sheet http://www.vuzix.com/role/AccruedExpenses Accrued Expenses Notes 9 false false R10.htm 110 - Disclosure - Derivative Liability and Fair Value Measurements Sheet http://www.vuzix.com/role/DerivativeLiabilityAndFairValueMeasurements Derivative Liability and Fair Value Measurements Notes 10 false false R11.htm 111 - Disclosure - Long-Term Debt Sheet http://www.vuzix.com/role/LongtermDebt Long-Term Debt Notes 11 false false R12.htm 112 - Disclosure - Income Taxes Sheet http://www.vuzix.com/role/IncomeTaxes Income Taxes Notes 12 false false R13.htm 113 - Disclosure - Capital Stock Sheet http://www.vuzix.com/role/CapitalStock Capital Stock Notes 13 false false R14.htm 114 - Disclosure - Stock Warrants Sheet http://www.vuzix.com/role/StockWarrants Stock Warrants Notes 14 false false R15.htm 115 - Disclosure - Stock Option Plans Sheet http://www.vuzix.com/role/StockOptionPlans Stock Option Plans Notes 15 false false R16.htm 116 - Disclosure - Litigation Sheet http://www.vuzix.com/role/Litigation Litigation Notes 16 false false R17.htm 117 - Disclosure - Contractual Obligations Sheet http://www.vuzix.com/role/ContractualObligations Contractual Obligations Notes 17 false false R18.htm 118 - Disclosure - Recent Accounting Pronouncements Sheet http://www.vuzix.com/role/RecentAccountingPronouncements Recent Accounting Pronouncements Notes 18 false false R19.htm 119 - Disclosure - Inventories, Net (Tables) Sheet http://www.vuzix.com/role/InventoriesNetTables Inventories, Net (Tables) Tables http://www.vuzix.com/role/InventoriesNet 19 false false R20.htm 120 - Disclosure - Accrued Expenses (Tables) Sheet http://www.vuzix.com/role/AccruedExpensesTables Accrued Expenses (Tables) Tables http://www.vuzix.com/role/AccruedExpenses 20 false false R21.htm 121 - Disclosure - Derivative Liability and Fair Value Measurements (Tables) Sheet http://www.vuzix.com/role/DerivativeLiabilityAndFairValueMeasurementsTables Derivative Liability and Fair Value Measurements (Tables) Tables http://www.vuzix.com/role/DerivativeLiabilityAndFairValueMeasurements 21 false false R22.htm 122 - Disclosure - Long-Term Debt (Tables) Sheet http://www.vuzix.com/role/LongtermDebtTables Long-Term Debt (Tables) Tables http://www.vuzix.com/role/LongtermDebt 22 false false R23.htm 123 - Disclosure - Stock Warrants (Tables) Sheet http://www.vuzix.com/role/StockWarrantsTables Stock Warrants (Tables) Tables http://www.vuzix.com/role/StockWarrants 23 false false R24.htm 124 - Disclosure - Stock Option Plans (Tables) Sheet http://www.vuzix.com/role/StockOptionPlansTables Stock Option Plans (Tables) Tables http://www.vuzix.com/role/StockOptionPlans 24 false false R25.htm 125 - Disclosure - Contractual Obligations (Tables) Sheet http://www.vuzix.com/role/ContractualObligationsTables Contractual Obligations (Tables) Tables http://www.vuzix.com/role/ContractualObligations 25 false false R26.htm 126 - Disclosure - Basis of Presentation (Additional Information) (Detail) Sheet http://www.vuzix.com/role/BasisOfPresentationAdditionalInformationDetail Basis of Presentation (Additional Information) (Detail) Details http://www.vuzix.com/role/BasisOfPresentation 26 false false R27.htm 127 - Disclosure - Loss Per Share (Additional Information) (Detail) Sheet http://www.vuzix.com/role/LossPerShareAdditionalInformationDetail Loss Per Share (Additional Information) (Detail) Details http://www.vuzix.com/role/LossPerShare 27 false false R28.htm 128 - Disclosure - Inventories, Net (Components of Inventories) (Detail) Sheet http://www.vuzix.com/role/InventoriesNetComponentsOfInventoriesDetail Inventories, Net (Components of Inventories) (Detail) Details http://www.vuzix.com/role/InventoriesNetTables 28 false false R29.htm 129 - Disclosure - Accrued Expenses (Components of Accrued Expenses) (Detail) Sheet http://www.vuzix.com/role/AccruedExpensesComponentsOfAccruedExpensesDetail Accrued Expenses (Components of Accrued Expenses) (Detail) Details http://www.vuzix.com/role/AccruedExpensesTables 29 false false R30.htm 130 - Disclosure - Accrued Expenses (Changes in Accrued Warranty Obligations) (Detail) Sheet http://www.vuzix.com/role/AccruedExpensesChangesInAccruedWarrantyObligationsDetail Accrued Expenses (Changes in Accrued Warranty Obligations) (Detail) Details http://www.vuzix.com/role/AccruedExpensesTables 30 false false R31.htm 131 - Disclosure - Accrued Expenses - Additional Information (Detail) Sheet http://www.vuzix.com/role/AccruedExpensesAdditionalInformationDetail Accrued Expenses - Additional Information (Detail) Details 31 false false R32.htm 132 - Disclosure - Derivative Liability and Fair Value Measurements (Schedule of Assets And Liabilities Measured At Fair Value On A Recurring Basis) (Detail) Sheet http://www.vuzix.com/role/DerivativeLiabilityAndFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail Derivative Liability and Fair Value Measurements (Schedule of Assets And Liabilities Measured At Fair Value On A Recurring Basis) (Detail) Details http://www.vuzix.com/role/DerivativeLiabilityAndFairValueMeasurementsTables 32 false false R33.htm 133 - Disclosure - Derivative Liability and Fair Value Measurements (Schedule of Fair Value Level 3 Warrant Liabilities) (Detail) Sheet http://www.vuzix.com/role/DerivativeLiabilityAndFairValueMeasurementsScheduleOfFairValueLevel3WarrantLiabilitiesDetail Derivative Liability and Fair Value Measurements (Schedule of Fair Value Level 3 Warrant Liabilities) (Detail) Details http://www.vuzix.com/role/DerivativeLiabilityAndFairValueMeasurementsTables 33 false false R34.htm 134 - Disclosure - Derivative Liability and Fair Value Measurements (Estimate the fair value of warrants outstanding) (Detail) Sheet http://www.vuzix.com/role/DerivativeLiabilityAndFairValueMeasurementsEstimateFairValueOfWarrantsOutstandingDetail Derivative Liability and Fair Value Measurements (Estimate the fair value of warrants outstanding) (Detail) Details http://www.vuzix.com/role/DerivativeLiabilityAndFairValueMeasurementsTables 34 false false R35.htm 135 - Disclosure - Derivative Liability and Fair Value Measurements (Additional Information) (Detail) Sheet http://www.vuzix.com/role/DerivativeLiabilityAndFairValueMeasurementsAdditionalInformationDetail Derivative Liability and Fair Value Measurements (Additional Information) (Detail) Details http://www.vuzix.com/role/DerivativeLiabilityAndFairValueMeasurementsTables 35 false false R36.htm 136 - Disclosure - Long-Term Debt (Components of Long-Term Debt) (Detail) Sheet http://www.vuzix.com/role/LongtermDebtComponentsOfLongtermDebtDetail Long-Term Debt (Components of Long-Term Debt) (Detail) Details http://www.vuzix.com/role/LongtermDebtTables 36 false false R37.htm 137 - Disclosure - Long-Term Debt (Components of Long-Term Debt) (Parenthetical) (Detail) Sheet http://www.vuzix.com/role/LongtermDebtComponentsOfLongtermDebtParentheticalDetail Long-Term Debt (Components of Long-Term Debt) (Parenthetical) (Detail) Details http://www.vuzix.com/role/LongtermDebtTables 37 false false R38.htm 138 - Disclosure - Long-Term Debt (Aggregate Maturities For All Long Term Borrowings) (Detail) Sheet http://www.vuzix.com/role/LongtermDebtAggregateMaturitiesForAllLongTermBorrowingsDetail Long-Term Debt (Aggregate Maturities For All Long Term Borrowings) (Detail) Details http://www.vuzix.com/role/LongtermDebtTables 38 false false R39.htm 139 - Disclosure - Long-Term Debt (Additional Information) (Detail) Sheet http://www.vuzix.com/role/LongtermDebtAdditionalInformationDetail Long-Term Debt (Additional Information) (Detail) Details http://www.vuzix.com/role/LongtermDebtTables 39 false false R40.htm 140 - Disclosure - Capital Stock (Additional Information) (Detail) Sheet http://www.vuzix.com/role/CapitalStockAdditionalInformationDetail Capital Stock (Additional Information) (Detail) Details http://www.vuzix.com/role/CapitalStock 40 false false R41.htm 141 - Disclosure - Stock Warrants (Changes in Warrants) (Detail) Sheet http://www.vuzix.com/role/StockWarrantsChangesInWarrantsDetail Stock Warrants (Changes in Warrants) (Detail) Details http://www.vuzix.com/role/StockWarrantsTables 41 false false R42.htm 142 - Disclosure - Stock Warrants (Additional Information) (Detail) Sheet http://www.vuzix.com/role/StockWarrantsAdditionalInformationDetail Stock Warrants (Additional Information) (Detail) Details http://www.vuzix.com/role/StockWarrantsTables 42 false false R43.htm 143 - Disclosure - Stock Option Plans (Summary of Stock Option Activity) (Detail) Sheet http://www.vuzix.com/role/StockOptionPlansSummaryOfStockOptionActivityDetail Stock Option Plans (Summary of Stock Option Activity) (Detail) Details http://www.vuzix.com/role/StockOptionPlansTables 43 false false R44.htm 144 - Disclosure - Stock Option Plans (Assumptions Used To Compute The Fair Value Of Stock Options) (Detail) Sheet http://www.vuzix.com/role/StockOptionPlansAssumptionsUsedToComputeFairValueOfStockOptionsDetail Stock Option Plans (Assumptions Used To Compute The Fair Value Of Stock Options) (Detail) Details http://www.vuzix.com/role/StockOptionPlansTables 44 false false R45.htm 145 - Disclosure - Stock Option Plans (Additional Information) (Detail) Sheet http://www.vuzix.com/role/StockOptionPlansAdditionalInformationDetail Stock Option Plans (Additional Information) (Detail) Details http://www.vuzix.com/role/StockOptionPlansTables 45 false false R46.htm 146 - Disclosure - Contractual Obligations (Future Minimum Payments Required Under Operating Lease) (Detail) Sheet http://www.vuzix.com/role/ContractualObligationsFutureMinimumPaymentsRequiredUnderOperatingLeaseDetail Contractual Obligations (Future Minimum Payments Required Under Operating Lease) (Detail) Details http://www.vuzix.com/role/ContractualObligationsTables 46 false false R47.htm 147 - Disclosure - Contractual Obligations (Additional Information) (Detail) Sheet http://www.vuzix.com/role/ContractualObligationsAdditionalInformationDetail Contractual Obligations (Additional Information) (Detail) Details http://www.vuzix.com/role/ContractualObligationsTables 47 false false All Reports Book All Reports vuzi-20160930.xml vuzi-20160930.xsd vuzi-20160930_cal.xml vuzi-20160930_def.xml vuzi-20160930_lab.xml vuzi-20160930_pre.xml true true ZIP 65 0001144204-16-133603-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001144204-16-133603-xbrl.zip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end